0001120970 Comstock Inc. false --12-31 Q1 2026 0.000666 0.000666 50,000,000 50,000,000 0 0 0.000666 0.000666 245,000,000 245,000,000 74,099,140 74,099,140 51,853,490 51,853,490 0 0 35,662 13.34 13.34 0 0 0 0 0 29,852 http://fasb.org/us-gaap/2026#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2026#OtherNonoperatingIncomeExpense 66,666 55 55 19,053 19,053 60 523,890 5 238,379 14,908 73,792 28,116 20 0 0 0 http://fasb.org/us-gaap/2026#ConvertibleDebtNoncurrent http://fasb.org/us-gaap/2026#ConvertibleDebtNoncurrent 0.25 12.0 0.75 0.25 12.0 0.84 5 3 1 3 1 6,050,000 4,688 false false false false Mining segment - asset held for sale (see Note 6) 0001120970 2026-01-01 2026-03-31 xbrli:shares 0001120970 2026-05-04 thunderdome:item iso4217:USD 0001120970 2026-03-31 0001120970 2025-12-31 0001120970 lode:MarathonSafeNoteLiabilityMember 2026-03-31 0001120970 lode:MarathonSafeNoteLiabilityMember 2025-12-31 iso4217:USD xbrli:shares 0001120970 2025-01-01 2025-03-31 0001120970 us-gaap:CommonStockMember 2024-12-31 0001120970 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001120970 us-gaap:RetainedEarningsMember 2024-12-31 0001120970 us-gaap:NoncontrollingInterestMember 2024-12-31 0001120970 2024-12-31 0001120970 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001120970 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001120970 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001120970 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0001120970 lode:AstLeaseAmendmentMember us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001120970 lode:AstLeaseAmendmentMember us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001120970 lode:AstLeaseAmendmentMember us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001120970 lode:AstLeaseAmendmentMember us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0001120970 lode:AstLeaseAmendmentMember 2025-01-01 2025-03-31 0001120970 us-gaap:CommonStockMember 2025-03-31 0001120970 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001120970 us-gaap:RetainedEarningsMember 2025-03-31 0001120970 us-gaap:NoncontrollingInterestMember 2025-03-31 0001120970 2025-03-31 0001120970 us-gaap:CommonStockMember 2025-12-31 0001120970 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001120970 us-gaap:RetainedEarningsMember 2025-12-31 0001120970 us-gaap:NoncontrollingInterestMember 2025-12-31 0001120970 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001120970 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001120970 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001120970 us-gaap:NoncontrollingInterestMember 2026-01-01 2026-03-31 0001120970 us-gaap:CommonStockMember 2026-03-31 0001120970 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001120970 us-gaap:RetainedEarningsMember 2026-03-31 0001120970 us-gaap:NoncontrollingInterestMember 2026-03-31 0001120970 lode:ExcludingFluxPhotonMember 2026-01-01 2026-03-31 0001120970 lode:ExcludingFluxPhotonMember 2025-01-01 2025-03-31 0001120970 lode:MetalsRecyclingMember 2026-01-01 2026-03-31 0001120970 lode:MetalsRecyclingMember 2025-01-01 2025-03-31 0001120970 lode:FluxPhotonMember 2026-01-01 2026-03-31 0001120970 lode:FluxPhotonMember 2025-01-01 2025-03-31 0001120970 lode:ComstockMetalsMember 2026-01-01 2026-03-31 0001120970 lode:ComstockMetalsMember 2025-01-01 2025-03-31 0001120970 lode:RenfuelNoteReceivableMember 2026-01-01 2026-03-31 0001120970 lode:RenfuelNoteReceivableMember 2025-01-01 2025-03-31 0001120970 lode:HexasSafeMember 2026-01-01 2026-03-31 0001120970 lode:HexasSafeMember 2025-01-01 2025-03-31 0001120970 lode:SierraSpringsOpportunityFundIncSSOFMember 2026-01-01 2026-03-31 0001120970 lode:SierraSpringsOpportunityFundIncSSOFMember 2025-01-01 2025-03-31 0001120970 lode:DebtAndAccruedInterestConvertedIntoCommonSharesMember 2026-01-01 2026-03-31 0001120970 lode:DebtAndAccruedInterestConvertedIntoCommonSharesMember 2025-01-01 2025-03-31 0001120970 lode:AstLeaseAmendmentMember 2026-01-01 2026-03-31 xbrli:pure 0001120970 lode:HexasMember 2025-12-04 0001120970 lode:HexasMember 2026-01-01 2026-03-31 0001120970 lode:HexasMember 2025-01-01 2025-03-31 0001120970 lode:ResearchAndDevelopmentCompanyMember 2026-03-31 0001120970 lode:ResearchAndDevelopmentCompanyMember 2025-12-31 0001120970 lode:SierraSpringsOpportunityFundIncSSOFMember 2026-03-31 0001120970 lode:SierraSpringsOpportunityFundIncSSOFMember 2025-12-31 0001120970 lode:GreenLiionPteLtdMember 2026-03-31 0001120970 lode:GreenLiionPteLtdMember 2025-12-31 0001120970 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2026-01-01 2026-03-31 0001120970 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2025-01-01 2025-03-31 0001120970 lode:ResearchAndDevelopmentCompanyMember 2024-03-01 2024-03-01 0001120970 lode:ResearchAndDevelopmentCompanyMember 2026-01-01 2026-03-31 0001120970 lode:ResearchAndDevelopmentCompanyMember 2025-01-01 2025-03-31 0001120970 lode:SierraSpringsOpportunityFundIncSSOFMember 2019-01-01 2025-12-31 0001120970 lode:SierraSpringsOpportunityFundIncSSOFMember 2026-01-01 2026-03-31 0001120970 lode:SierraSpringsOpportunityFundIncSSOFMember 2025-01-01 2025-12-31 0001120970 lode:ConversionOfSierraSpringsAdvancesIntoSierraSpringsCommonStockMember 2026-01-01 2026-03-31 0001120970 lode:ConversionOfSierraSpringsAdvancesIntoSierraSpringsCommonStockMember 2026-03-30 2026-03-30 0001120970 lode:GreenLiionPteLtdMember 2026-01-01 2026-03-31 0001120970 lode:GreenLiionPteLtdMember 2025-01-01 2025-03-31 0001120970 lode:SierraSpringsOpportunityFundIncNoteReceivableMember 2026-03-31 0001120970 lode:SierraSpringsOpportunityFundIncNoteReceivableMember 2025-12-31 0001120970 lode:DaneyRanchSaleNoteReceivableMember 2026-03-31 0001120970 lode:DaneyRanchSaleNoteReceivableMember 2025-12-31 0001120970 lode:SierraSpringsOpportunityFundIncNoteReceivableMember 2025-01-01 2025-12-31 0001120970 lode:SierraSpringsOpportunityFundIncNoteReceivableMember 2026-01-01 2026-03-31 0001120970 lode:ConversionOfSierraSpringsAdvancesIntoSierraSpringsCommonStockMember 2026-03-26 2026-03-26 0001120970 us-gaap:LandMember 2026-03-31 0001120970 us-gaap:LandMember 2025-12-31 0001120970 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2026-03-31 0001120970 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2025-12-31 0001120970 lode:MineralProcessingMember 2026-03-31 0001120970 lode:MineralProcessingMember 2025-12-31 0001120970 lode:FuelsProcessingMember 2026-03-31 0001120970 lode:FuelsProcessingMember 2025-12-31 0001120970 lode:SolarPanelRecyclingMember 2026-03-31 0001120970 lode:SolarPanelRecyclingMember 2025-12-31 0001120970 us-gaap:ConstructionInProgressMember 2026-03-31 0001120970 us-gaap:ConstructionInProgressMember 2025-12-31 0001120970 us-gaap:PropertyPlantAndEquipmentOtherTypesMember 2026-03-31 0001120970 us-gaap:PropertyPlantAndEquipmentOtherTypesMember 2025-12-31 0001120970 us-gaap:DepositsMember 2026-03-31 0001120970 us-gaap:DepositsMember 2025-12-31 0001120970 lode:ComstockMineralEstateMember 2026-03-31 0001120970 lode:ComstockMineralEstateMember 2025-12-31 0001120970 lode:OtherMineralPropertiesMember 2026-03-31 0001120970 lode:OtherMineralPropertiesMember 2025-12-31 0001120970 lode:WaterRightsMember 2026-03-31 0001120970 lode:WaterRightsMember 2025-12-31 0001120970 lode:BindingMipaWithMackayMember 2025-06-06 0001120970 lode:BindingMipaWithMackayMember 2024-12-18 0001120970 lode:NsrRoyaltyAgreementMember 2026-01-09 0001120970 lode:NsrRoyaltyAgreementFebruary2026AmendmentMember 2026-02-22 0001120970 us-gaap:DiscontinuedOperationsHeldforsaleMember 2026-03-31 utr:Y 0001120970 us-gaap:DevelopedTechnologyRightsMember 2026-03-31 0001120970 us-gaap:DevelopedTechnologyRightsMember 2025-12-31 0001120970 us-gaap:LicensingAgreementsMember 2026-03-31 0001120970 us-gaap:LicensingAgreementsMember 2025-12-31 0001120970 us-gaap:DistributionRightsMember 2026-03-31 0001120970 us-gaap:DistributionRightsMember 2025-12-31 0001120970 lode:ResearchAndDevelopmentCompanyMember 2026-03-31 0001120970 lode:ResearchAndDevelopmentCompanyMember 2025-12-31 0001120970 lode:FluxPhotonCorporationFPCMember 2026-03-31 0001120970 lode:FluxPhotonCorporationFPCMember 2025-12-31 0001120970 lode:OklahomaGrantMember 2024-12-11 0001120970 lode:OklahomaGrantMember 2026-01-20 2026-01-20 0001120970 lode:OklahomaGrantMember 2026-01-01 2026-03-31 0001120970 lode:OklahomaGrantMember 2025-01-01 2025-03-31 0001120970 lode:OklahomaGrantMember 2026-03-31 0001120970 lode:OklahomaGrantMember 2025-12-31 utr:M 0001120970 lode:NavitasEquipmentLeaseAgreementMember 2026-03-11 0001120970 lode:NavitasEquipmentLeaseAgreementMember 2026-03-31 0001120970 lode:IndustrialAndCommercialLeaseMember 2026-03-31 0001120970 lode:NavitasEquipmentLeaseAgreementMember 2026-01-01 2026-03-31 0001120970 lode:IndustrialAndCommercialLeaseMember 2026-01-01 2026-03-31 0001120970 lode:CambridgeLandAndPremisesLeaseMember 2026-01-06 0001120970 lode:CambridgeLandAndPremisesLeaseMember 2026-01-01 2026-03-31 0001120970 lode:HydrotreatingEquipmentLeaseMember 2026-03-01 0001120970 2026-03-01 0001120970 lode:HydrotreatingEquipmentLeaseMember 2026-01-01 2026-03-31 0001120970 lode:PropertyAt700LakeAvenueMember 2026-01-01 2026-03-31 0001120970 lode:PropertyAt700LakeAvenueMember 2025-01-01 2025-03-31 0001120970 lode:PropertyAt600LakeAvenueMember 2024-07-01 0001120970 lode:PropertyAt600LakeAvenueMember 2026-01-01 2026-02-28 0001120970 lode:PropertyAt600LakeAvenueMember 2026-01-01 2026-03-31 0001120970 lode:PropertyAt800LakeAvenueMember 2025-11-01 0001120970 lode:PropertyAt800LakeAvenueMember 2026-01-01 2026-03-31 0001120970 lode:AstLicenseAgreementMember 2026-03-31 0001120970 lode:AstLicenseAgreementMember 2022-12-31 0001120970 lode:AstLicenseAgreementMember 2026-01-01 2026-03-31 0001120970 lode:PrecedentAgreementMember 2025-11-29 2025-11-29 utr:Btu 0001120970 srt:ScenarioForecastMember lode:PrecedentAgreementMember 2027-12-31 2027-12-31 0001120970 lode:PrecedentAgreementMember 2026-03-31 0001120970 lode:LicensedTechnologyRAndDProjectsMember 2026-01-01 2026-03-31 0001120970 lode:LicensedTechnologyRAndDProjectsMember 2025-01-01 2025-03-31 0001120970 lode:LicensedTechnologyRAndDProjectsMember 2024-03-01 0001120970 lode:LicensedTechnologyRAndDProjectsMember 2026-03-31 0001120970 lode:NrelAggreementMember srt:ScenarioForecastMember 2026-12-31 0001120970 lode:NrelAggreementMember srt:ScenarioForecastMember 2027-12-31 0001120970 lode:NrelAggreementMember 2025-01-01 2025-12-31 0001120970 lode:NrelAggreementMember 2026-01-01 2026-03-31 0001120970 lode:NrelAggreementMember 2025-01-01 2025-03-31 0001120970 lode:NrelAggreementMember 2024-10-01 0001120970 lode:NrelAggreementMember 2026-03-31 0001120970 lode:NrelAggreementMember srt:MinimumMember 2026-03-31 0001120970 lode:ComstockFuelsEquityMember 2025-02-28 0001120970 lode:ComstockFuelsEquityMember srt:MaximumMember 2025-02-28 0001120970 lode:ComstockFuelsEquityMember 2025-02-28 2025-02-28 0001120970 lode:ComstockFuelsEquityMember srt:MaximumMember 2025-02-28 2025-02-28 0001120970 lode:ComstockFuelsEquityMember 2026-03-31 0001120970 srt:DirectorMember 2026-01-01 2026-03-31 0001120970 lode:TheChairOfEachCommitteeMember 2026-01-01 2026-03-31 0001120970 srt:DirectorMember 2025-01-01 2025-03-31 0001120970 lode:ConfidentiallyMarketedPublicOfferingMember 2026-01-28 2026-01-28 0001120970 lode:ConfidentiallyMarketedPublicOfferingMember 2026-01-28 0001120970 lode:ConfidentiallyMarketedPublicOfferingMember 2026-03-03 2026-03-03 0001120970 lode:ConfidentiallyMarketedPublicOfferingMember 2026-03-03 0001120970 2026-03-03 2026-03-03 0001120970 lode:NonemployeeDirectorsMember 2026-01-05 2026-01-05 0001120970 lode:NonemployeeDirectorsMember 2026-01-05 0001120970 lode:TitanAtTheMarketOfferingAgreement2025Member 2025-11-21 0001120970 lode:TitanAtTheMarketOfferingAgreement2025Member 2026-01-01 2026-03-31 0001120970 lode:TitanAtTheMarketOfferingAgreement2025Member 2026-03-31 0001120970 lode:TitanAtTheMarketOfferingAgreement2025Member 2025-01-01 2025-12-31 0001120970 lode:TitanAtTheMarketOfferingAgreement2025Member 2025-12-31 0001120970 lode:ConversionOfKipsBayNote2025ToCommonStockMember lode:RegisteredStockMember 2025-02-03 2025-02-03 0001120970 lode:ConversionOfKipsBayNote2025ToCommonStockMember lode:RegisteredStockMember 2025-02-03 0001120970 lode:AlvinFundMember 2025-01-01 2025-03-31 0001120970 lode:AmericanScienceAndTechnologyCorporationAstMember 2025-03-20 2025-03-20 0001120970 lode:FormerLinicoChiefExecutiveOfficerMember 2025-02-28 2025-02-28 0001120970 lode:KipsBaySelectLPMember 2025-01-27 2025-01-27 0001120970 lode:Warrant1Member 2026-03-31 0001120970 lode:Warrant1Member 2025-12-31 0001120970 lode:Warrant2Member 2026-03-31 0001120970 lode:Warrant2Member 2025-12-31 0001120970 lode:Warrant3Member 2026-03-31 0001120970 lode:Warrant3Member 2025-12-31 0001120970 lode:Warrant4Member 2026-03-31 0001120970 lode:Warrant4Member 2025-12-31 0001120970 lode:UnderwriterPurchaseWarrants1Member 2026-03-31 0001120970 lode:UnderwriterPurchaseWarrants1Member 2025-12-31 0001120970 lode:UnderwriterPurchaseWarrants2Member 2026-03-31 0001120970 lode:UnderwriterPurchaseWarrants2Member 2025-12-31 0001120970 lode:UnderwriterPurchaseWarrantsAugust142025Member 2026-03-31 0001120970 lode:UnderwriterPurchaseWarrantsSeptember152025Member 2026-03-31 0001120970 lode:UnderwriterPurchaseWarrantsJanuary302026Member 2026-03-31 0001120970 lode:UnderwriterPurchaseWarrantsMarch32026Member 2026-03-31 0001120970 lode:GeorgesTrustDerivativeInstrumentMember us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001120970 lode:GeorgesTrustDerivativeInstrumentMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001120970 lode:GeorgesTrustDerivativeInstrumentMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001120970 lode:GeorgesTrustDerivativeInstrumentMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001120970 us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001120970 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001120970 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001120970 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001120970 lode:MarathonSafeNoteLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001120970 lode:MarathonSafeNoteLiabilityMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001120970 lode:MarathonSafeNoteLiabilityMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001120970 lode:MarathonSafeNoteLiabilityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001120970 lode:GeorgesTrustDerivativeInstrumentMember us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001120970 lode:GeorgesTrustDerivativeInstrumentMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001120970 lode:GeorgesTrustDerivativeInstrumentMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001120970 lode:GeorgesTrustDerivativeInstrumentMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001120970 lode:AlvinFundDerivativeInstrumentMember us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001120970 lode:AlvinFundDerivativeInstrumentMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001120970 lode:AlvinFundDerivativeInstrumentMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001120970 lode:AlvinFundDerivativeInstrumentMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001120970 us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001120970 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001120970 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001120970 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001120970 lode:MarathonSafeNoteLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001120970 lode:MarathonSafeNoteLiabilityMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001120970 lode:MarathonSafeNoteLiabilityMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001120970 lode:MarathonSafeNoteLiabilityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001120970 lode:GeorgesTrustDerivativeInstrumentMember 2025-12-31 0001120970 lode:GeorgesTrustDerivativeInstrumentMember 2026-01-01 2026-03-31 0001120970 lode:GeorgesTrustDerivativeInstrumentMember 2026-03-31 0001120970 lode:AlvinFundDerivativeInstrumentMember 2025-12-31 0001120970 lode:AlvinFundDerivativeInstrumentMember 2026-01-01 2026-03-31 0001120970 lode:AlvinFundDerivativeInstrumentMember 2026-03-31 0001120970 lode:KipsBay2025ConversionOptionDerivativeMember 2024-12-31 0001120970 lode:KipsBay2025ConversionOptionDerivativeMember 2025-01-01 2025-03-31 0001120970 lode:KipsBay2025ConversionOptionDerivativeMember 2025-03-31 0001120970 lode:LinicoAcquisitionDerivativeInstrumentMember 2024-12-31 0001120970 lode:LinicoAcquisitionDerivativeInstrumentMember 2025-01-01 2025-03-31 0001120970 lode:LinicoAcquisitionDerivativeInstrumentMember 2025-03-31 0001120970 lode:ASTDerivativeInstrumentMember 2024-12-31 0001120970 lode:ASTDerivativeInstrumentMember 2025-01-01 2025-03-31 0001120970 lode:ASTDerivativeInstrumentMember 2025-03-31 0001120970 lode:HaywoodDerivativeInstrumentMember 2024-12-31 0001120970 lode:HaywoodDerivativeInstrumentMember 2025-01-01 2025-03-31 0001120970 lode:HaywoodDerivativeInstrumentMember 2025-03-31 0001120970 lode:ConversionOfTheAmendedGhfInc2021NotesIntoCommonStockMember 2025-08-13 2025-08-13 0001120970 2025-08-13 0001120970 lode:GeorgesTrustDerivativeInstrumentMember 2025-08-13 2025-08-13 0001120970 lode:ConversionOfTrueUpProvisionMember 2025-08-13 2025-08-13 0001120970 lode:GeorgesTrustDerivativeInstrumentMember 2026-03-30 2026-03-30 0001120970 lode:ConversionOfTrueUpProvisionMember 2026-01-01 2026-03-31 0001120970 lode:GeorgesTrustDerivativeInstrumentMember us-gaap:FairValueInputsLevel2Member 2026-01-01 2026-03-31 0001120970 lode:GeorgesTrustMember 2026-03-31 0001120970 lode:ConversionOfTheAlvinFund2022NoteAndAlvinFund2023NoteIntoCommonSharesMember 2025-08-12 2025-08-12 0001120970 2025-08-12 0001120970 lode:AlvinFundDerivativeInstrumentMember 2025-08-12 2025-08-12 0001120970 lode:ConversionOfTheAmendedAlvinFund2022NoteIntoCommonSharesMember 2025-08-12 0001120970 lode:ConversionOfTheAmendedAlvinFund2022NoteIntoCommonSharesMember 2026-01-01 2026-03-31 0001120970 lode:ExtinguishmentOfAlvinFundPromissoryNotesMember 2026-01-01 2026-03-31 0001120970 lode:MarathonSafeNoteLiabilityMember 2025-02-28 0001120970 lode:MarathonSafeNoteLiabilityMember us-gaap:MeasurementInputDiscountRateMember 2025-02-28 0001120970 lode:MarathonSafeNoteLiabilityMember lode:MeasurementInputDiscountPeriodMember srt:MinimumMember 2025-02-28 0001120970 lode:MarathonSafeNoteLiabilityMember lode:MeasurementInputDiscountPeriodMember srt:MaximumMember 2025-02-28 0001120970 lode:MarathonSafeNoteLiabilityMember 2026-03-31 0001120970 lode:MarathonSafeNoteLiabilityMember us-gaap:MeasurementInputCapRateMember 2026-03-31 0001120970 lode:MarathonSafeNoteLiabilityMember lode:MeasurementInputDiscountPeriodMember srt:MinimumMember 2026-03-31 0001120970 lode:MarathonSafeNoteLiabilityMember lode:MeasurementInputDiscountPeriodMember srt:MaximumMember 2026-03-31 0001120970 lode:MarathonSafeNoteLiabilityMember us-gaap:MeasurementInputDiscountRateMember srt:MinimumMember 2026-03-31 0001120970 lode:MarathonSafeNoteLiabilityMember us-gaap:MeasurementInputDiscountRateMember 2026-03-31 0001120970 lode:MarathonSafeNoteLiabilityMember us-gaap:MeasurementInputDiscountRateMember srt:MaximumMember 2026-03-31 0001120970 lode:MarathonSafeNoteLiabilityMember us-gaap:MeasurementInputDiscountRateMember srt:MinimumMember 2025-03-31 0001120970 lode:MarathonSafeNoteLiabilityMember us-gaap:MeasurementInputDiscountRateMember 2025-03-31 0001120970 lode:MarathonSafeNoteLiabilityMember us-gaap:MeasurementInputDiscountRateMember srt:MaximumMember 2025-03-31 0001120970 us-gaap:MeasurementInputCapRateMember lode:PrecedentAgreementMember 2026-03-31 0001120970 lode:MiningAndRealEstateMember lode:MetalsSegmentMember 2026-01-01 2026-03-31 0001120970 lode:MiningAndRealEstateMember lode:MiningSegmentMember 2026-01-01 2026-03-31 0001120970 lode:MiningAndRealEstateMember lode:StrategicInvestmentsSegmentMember 2026-01-01 2026-03-31 0001120970 lode:MiningAndRealEstateMember us-gaap:CorporateAndOtherMember 2026-01-01 2026-03-31 0001120970 lode:MiningAndRealEstateMember lode:BioleumSegmentMember 2026-01-01 2026-03-31 0001120970 lode:MiningAndRealEstateMember 2026-01-01 2026-03-31 0001120970 lode:RecyclingMember lode:MetalsSegmentMember 2026-01-01 2026-03-31 0001120970 lode:RecyclingMember lode:MiningSegmentMember 2026-01-01 2026-03-31 0001120970 lode:RecyclingMember lode:StrategicInvestmentsSegmentMember 2026-01-01 2026-03-31 0001120970 lode:RecyclingMember us-gaap:CorporateAndOtherMember 2026-01-01 2026-03-31 0001120970 lode:RecyclingMember lode:BioleumSegmentMember 2026-01-01 2026-03-31 0001120970 lode:RecyclingMember 2026-01-01 2026-03-31 0001120970 lode:DecommissioningServicesMember lode:MetalsSegmentMember 2026-01-01 2026-03-31 0001120970 lode:DecommissioningServicesMember lode:MiningSegmentMember 2026-01-01 2026-03-31 0001120970 lode:DecommissioningServicesMember lode:StrategicInvestmentsSegmentMember 2026-01-01 2026-03-31 0001120970 lode:DecommissioningServicesMember us-gaap:CorporateAndOtherMember 2026-01-01 2026-03-31 0001120970 lode:DecommissioningServicesMember lode:BioleumSegmentMember 2026-01-01 2026-03-31 0001120970 lode:DecommissioningServicesMember 2026-01-01 2026-03-31 0001120970 lode:OfftakeMember lode:MetalsSegmentMember 2026-01-01 2026-03-31 0001120970 lode:OfftakeMember lode:MiningSegmentMember 2026-01-01 2026-03-31 0001120970 lode:OfftakeMember lode:StrategicInvestmentsSegmentMember 2026-01-01 2026-03-31 0001120970 lode:OfftakeMember us-gaap:CorporateAndOtherMember 2026-01-01 2026-03-31 0001120970 lode:OfftakeMember lode:BioleumSegmentMember 2026-01-01 2026-03-31 0001120970 lode:OfftakeMember 2026-01-01 2026-03-31 0001120970 lode:MetalsSegmentMember 2026-01-01 2026-03-31 0001120970 lode:MiningSegmentMember 2026-01-01 2026-03-31 0001120970 lode:StrategicInvestmentsSegmentMember 2026-01-01 2026-03-31 0001120970 us-gaap:CorporateAndOtherMember 2026-01-01 2026-03-31 0001120970 lode:BioleumSegmentMember 2026-01-01 2026-03-31 0001120970 lode:MiningAndRealEstateMember lode:MetalsSegmentMember 2025-01-01 2025-03-31 0001120970 lode:MiningAndRealEstateMember lode:MiningSegmentMember 2025-01-01 2025-03-31 0001120970 lode:MiningAndRealEstateMember lode:StrategicInvestmentsSegmentMember 2025-01-01 2025-03-31 0001120970 lode:MiningAndRealEstateMember us-gaap:CorporateAndOtherMember 2025-01-01 2025-03-31 0001120970 lode:MiningAndRealEstateMember lode:BioleumSegmentMember 2025-01-01 2025-03-31 0001120970 lode:MiningAndRealEstateMember 2025-01-01 2025-03-31 0001120970 lode:DecommissioningServicesMember lode:MetalsSegmentMember 2025-01-01 2025-03-31 0001120970 lode:DecommissioningServicesMember lode:MiningSegmentMember 2025-01-01 2025-03-31 0001120970 lode:DecommissioningServicesMember lode:StrategicInvestmentsSegmentMember 2025-01-01 2025-03-31 0001120970 lode:DecommissioningServicesMember us-gaap:CorporateAndOtherMember 2025-01-01 2025-03-31 0001120970 lode:DecommissioningServicesMember lode:BioleumSegmentMember 2025-01-01 2025-03-31 0001120970 lode:DecommissioningServicesMember 2025-01-01 2025-03-31 0001120970 lode:OfftakeMember lode:MetalsSegmentMember 2025-01-01 2025-03-31 0001120970 lode:OfftakeMember lode:MiningSegmentMember 2025-01-01 2025-03-31 0001120970 lode:OfftakeMember lode:StrategicInvestmentsSegmentMember 2025-01-01 2025-03-31 0001120970 lode:OfftakeMember us-gaap:CorporateAndOtherMember 2025-01-01 2025-03-31 0001120970 lode:OfftakeMember lode:BioleumSegmentMember 2025-01-01 2025-03-31 0001120970 lode:OfftakeMember 2025-01-01 2025-03-31 0001120970 lode:MetalsSegmentMember 2025-01-01 2025-03-31 0001120970 lode:MiningSegmentMember 2025-01-01 2025-03-31 0001120970 lode:StrategicInvestmentsSegmentMember 2025-01-01 2025-03-31 0001120970 us-gaap:CorporateAndOtherMember 2025-01-01 2025-03-31 0001120970 lode:BioleumSegmentMember 2025-01-01 2025-03-31 0001120970 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-03-31 0001120970 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001120970 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-03-31 0001120970 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-12-31 0001120970 lode:ComstockMetalsMember 2026-03-31 0001120970 lode:RecyclingDecommissioningServicesAndOtherServicesMember lode:ComstockMetalsMember 2026-03-31 0001120970 lode:RecyclingMember lode:ComstockMetalsMember 2026-03-31 0001120970 lode:AllSegmentsExceptBioleumMember 2026-01-01 2026-03-31 0001120970 lode:AllSegmentsExceptBioleumMember 2025-01-01 2025-03-31 0001120970 lode:MetalsSegmentMember 2026-03-31 0001120970 lode:MiningSegmentMember 2026-03-31 0001120970 lode:StrategicInvestmentsSegmentMember 2026-03-31 0001120970 us-gaap:CorporateAndOtherMember 2026-03-31 0001120970 lode:AllSegmentsExceptBioleumMember 2026-03-31 0001120970 lode:BioleumSegmentMember 2026-03-31 0001120970 lode:MetalsSegmentMember 2025-03-31 0001120970 lode:MiningSegmentMember 2025-03-31 0001120970 lode:StrategicInvestmentsSegmentMember 2025-03-31 0001120970 us-gaap:CorporateAndOtherMember 2025-03-31 0001120970 lode:AllSegmentsExceptBioleumMember 2025-03-31 0001120970 lode:BioleumSegmentMember 2025-03-31 0001120970 lode:ConversionOfSierraSpringsAdvancesIntoSierraSpringsCommonStockMember 2025-12-31 2025-12-31 0001120970 lode:SSEMember lode:SierraSpringsOpportunityFundIncSSOFMember 2026-03-31 utr:acre 0001120970 lode:ChiefExecutiveOfficerAndTwoDirectorsMember lode:AdvancesToSierraSpringsOpportunityFundIncSSOFMember 2026-03-31 0001120970 lode:AssetPurchaseAgreementMember lode:FluxPhotonCorporationFPCMember 2021-09-07 2021-09-07 0001120970 lode:AssetPurchaseAgreementMember lode:FluxPhotonCorporationFPCMember 2021-09-07 0001120970 lode:FPCAssetPurchaseAgreementMember 2021-09-07 0001120970 lode:FPCAssetPurchaseAgreementMember 2021-12-10 2021-12-10 0001120970 lode:FPCAssetPurchaseAgreementMember 2023-12-28 2023-12-28 0001120970 lode:FPCAssetPurchaseAgreementMember 2024-01-01 2024-12-31 0001120970 lode:FPCAssetPurchaseAgreementMember 2021-09-07 2021-09-07 0001120970 lode:FPCAssetPurchaseAgreementMember 2025-05-21 2025-05-21 0001120970 lode:FPCAssetPurchaseAgreementMember 2025-05-21 0001120970 lode:FPCAssetPurchaseAgreementMember lode:FpcAssetsEarnOutMember 2025-05-21 0001120970 lode:FPCAssetPurchaseAgreementMember lode:FpcSettlementSharesMember 2025-05-21 2025-05-21 0001120970 lode:FPCAssetPurchaseAgreementMember lode:FpcAffiliatesMember 2025-01-01 2025-12-31 0001120970 lode:FPCAssetPurchaseAgreementMember 2025-01-01 2025-12-31 0001120970 lode:FPCAssetPurchaseAgreementMember lode:FpcAffiliatesMember 2026-03-31 0001120970 lode:FPCAssetPurchaseAgreementMember 2026-01-01 2026-03-31 0001120970 lode:FPCAssetPurchaseAgreementMember 2026-03-31 0001120970 lode:FPCAssetPurchaseAgreementMember 2025-01-01 2025-03-31 0001120970 lode:FluxPhotonMember 2026-03-31 0001120970 lode:FluxPhotonMember 2025-12-31 0001120970 lode:BioleumCorporationMember lode:FoundersGroupMember lode:Series2PreferredStockMember 2025-05-22 2025-05-22 0001120970 lode:DrVillamagnaMember 2023-12-15 2023-12-15 0001120970 lode:DrVillamagnaMember 2026-01-01 2026-03-31 0001120970 lode:DrVillamagnaMember 2025-01-01 2025-03-31 0001120970 lode:FPCAssetPurchaseAgreementMember lode:FpcSettlementSharesMember us-gaap:SubsequentEventMember 2026-04-06 2026-04-06 0001120970 lode:FPCAssetPurchaseAgreementMember lode:FpcSettlementSharesMember us-gaap:SubsequentEventMember 2026-04-06 0001120970 us-gaap:SubsequentEventMember lode:NonemployeeDirectorsMember 2026-04-06 2026-04-16 0001120970 lode:AdvancesToSierraSpringsOpportunityFundIncSSOFMember us-gaap:SubsequentEventMember 2026-04-30 2026-04-30 0001120970 lode:SierraSpringsOpportunityFundIncSSOFMember us-gaap:SubsequentEventMember 2026-04-30 0001120970 lode:GeorgesTrustMember us-gaap:SubsequentEventMember 2026-05-06 2026-05-06

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED March 31, 2026

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM ______ TO ______.

COMMISSION FILE NO.: 001-35200

COMSTOCK INC.

(Exact name of registrant as specified in its charter)

Nevada |  | 65-0955118
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)
117 American Flat Road, Virginia City, NV |  | 89440
(Address of principal executive offices) |  | (Zip Code)
| (775) 847-5272 |
| (Registrant’s telephone number) |
| Securities registered pursuant to Section 12(b) of the Act: |
Title of each class | Trading Symbol | Name of each exchange on which registered
Common Stock, par value $0.000666 per share | LODE | NYSE American

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. | Yes | ☒ | No | ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the prior 12 months (or for such shorter period that the registrant was required to submit such files). | Yes | ☒ | No | ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act. |  |  |  |

Large accelerated filer | ☐ |  | Accelerated filer | ☐ |  | Emerging growth company | ☐
Non-accelerated filer | ☒ |  | Smaller reporting company | ☒ |  |  |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. |  |  |  | ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). | Yes | ☐ | No | ☒
The number of shares outstanding of Common Stock, $0.000666 par value per share, on May 4, 2026 was 75,913,084. |  |  |  |

Table of Contents

This page intentionally left blank.

2

Table of Contents

COMSTOCK INC.

FORM 10-Q

FOR THE QUARTERLY PERIODS ENDED March 31, 2026 and 2025

TABLE OF CONTENTS

PART I – FINANCIAL INFORMATION
Item 1. Financial Statements. |
CONDENSED CONSOLIDATED BALANCE SHEETS | 5
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | 7
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY | 8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | 9
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS | 10
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. | 26
Item 3. Quantitative and Qualitative Disclosures About Market Risk. | 31
Item 4. Controls and Procedures. | 31
PART II – OTHER INFORMATION
Item 1. Legal Proceedings. | 32
Item 1A. Risk Factors. | 32
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. | 32
Item 3. Defaults Upon Senior Securities. | 32
Item 4. Mine Safety Disclosures. | 32
Item 5. Other Information. | 32
Item 6. Exhibits. | 33
Signatures | 34

3

Table of Contents

Cautionary Notice Regarding Forward-Looking Statements

Certain statements contained in this quarterly report on Form 10-Q are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, are forward-looking statements. The words “believe,” “expect,” “anticipate,” “estimate,” “project,” “plan,” “should,” “intend,” “may,” “will,” “would,” “potential” and similar expressions identify forward-looking statements but are not the exclusive means of doing so. Forward-looking statements include statements about matters such as: future market conditions; future explorations or acquisitions; divestitures, spin-offs or similar distribution transactions, future changes in our research, development and exploration activities; future financial, natural, and social gains; future prices and sales of, and demand for, our products and services; land entitlements and uses; permits; production capacity and operations; operating and overhead costs; future capital expenditures and their impact on us; operational and management changes (including changes in the Board of Directors); changes in business strategies, planning and tactics; future employment and contributions of personnel, including consultants; future land and asset sales; investments, acquisitions, divestitures, spin-offs or similar distribution transactions, joint ventures, strategic alliances, business combinations, operational, tax, financial and restructuring initiatives, including the nature, timing and accounting for restructuring charges, derivative assets and liabilities and the impact thereof; contingencies; litigation, administrative or arbitration proceedings; environmental compliance and changes in the regulatory environment; offerings, limitations on sales or offering of equity or debt securities, including asset sales and associated costs; business opportunities, growth rates, future capital needs, revenues, variable costs, throughput rates, operating expenses, debt levels, cash flows, margins, taxes and earnings.

These statements are based on assumptions and assessments made by our management in light of their experience and their perception of historical and current trends, current conditions, possible future developments and other factors they believe to be appropriate. Forward-looking statements are not guarantees, representations or warranties and are subject to risks and uncertainties, many of which are unforeseeable and beyond our control and could cause actual results, developments and business decisions to differ materially from those contemplated by such forward-looking statements. Some of those risks and uncertainties include the risk factors set forth in this report and our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and the following: adverse effects of climate changes or natural disasters; adverse effects of global or regional pandemic disease spread or other crises; global economic and capital market uncertainties; difficulties involved in developing renewable, decarbonizing and/or clean energy technologies, hazards and uncertainties associated with hazardous material and metal recycling, processing or mining and mineral extraction activities, the speculative nature of gold or mineral exploration, and aluminum, cadmium, copper, silica, silver, steel, and other metal and materials recycling, including risks of diminishing quantities or grades of qualified resources; operational or technical difficulties in connection with exploration, metal recycling, material processing or mining activities; costs, hazards and uncertainties associated with precious and other metal based activities, including environmentally friendly and economically enhancing, novel clean mining and processing technologies, precious metal exploration, resource development, economic feasibility assessment, environmental reclamations and historical restorations and cash generating mineral production; contests over our title to properties; potential dilution to our stockholders from our stock issuances, recapitalization and balance sheet restructuring activities; potential inability to comply with applicable government regulations or law; adoption of or changes in legislation or regulations adversely affecting our businesses; permitting constraints or delays; challenges to, or potential inability to, achieve the benefits of business opportunities, including research and development stage activities that may be presented to, or pursued by, us, including those involving quantum computing and material science based artificial intelligence supported advanced materials development and development services, development of cellulosic technology in bio-fuels and related material production; commercialization of cellulosic technology in bio-fuels; ability to successfully identify, finance, complete and integrate acquisitions, divestitures, spin-offs or similar distribution transactions, joint ventures, strategic alliances, collaborative research and development agreement, business combinations, asset and equity investment sales, and investments that we may be party to in the future; changes in the United States or other monetary or fiscal policies or regulations; interruptions in our production capabilities due to capital constraints; equipment failures; fluctuation of prices for gold or certain other commodities (such as aluminum, cadmium, copper, silica, silver, steel, and other metal and materials, cyanide, water, diesel, gasoline and alternative fuels and electricity); changes in generally accepted accounting principles; adverse effects of war, mass shooting, terrorism and geopolitical events; potential inability to implement our business strategies; potential inability to grow revenues; potential inability to attract and retain key personnel; interruptions in delivery of critical supplies, equipment and raw materials due to credit or other limitations imposed by vendors; assertion of claims, lawsuits and proceedings against us; potential inability to satisfy debt and lease obligations; potential inability to maintain an effective system of internal controls over financial reporting; potential inability or failure to timely file periodic reports with the Securities and Exchange Commission; potential inability to list our securities on any securities exchange or market or maintain the listing of our securities; and work stoppages or other labor difficulties. Occurrence of such events or circumstances could have a material adverse effect on our business, financial condition, results of operations or cash flows, or the market price of our securities. All subsequent written and oral forward-looking statements by or attributable to us or persons acting on our behalf are expressly qualified in their entirety by these factors. Except as may be required by securities or other law, we undertake no obligation to publicly update or revise any forward-looking statements, whether from new information, future events, or otherwise.

4

Table of Contents

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

COMSTOCK INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

|  | March 31, 2026 |  |  | December 31, 2025 |
ASSETS |  |  |  |  |  |  |  |
Current Assets: |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 52,967,801 |  |  | $ | 16,951,645 |
Accounts receivable |  |  | 311,600 |  |  |  | 1,287,722 |
Derivative assets (Note 11) |  |  | 136,114 |  |  |  | 1,960,796 |
Assets held for sale (Note 5) |  |  | 22,732,293 |  |  |  | — |
Prepaid expenses and other current assets |  |  | 819,720 |  |  |  | 457,816 |
Total current assets |  |  | 76,967,528 |  |  |  | 20,657,979 |
Non-current Assets: |  |  |  |  |  |  |  |
Investments (Note 3) |  |  | 56,403,592 |  |  |  | 39,505,436 |
Mineral rights and properties (Note 5) |  |  | 730,597 |  |  |  | 11,980,716 |
Properties, plant and equipment, net (Note 5) |  |  | 36,096,380 |  |  |  | 29,886,209 |
Deposits - equipment |  |  | 2,561,182 |  |  |  | 8,002,643 |
Reclamation bond deposit |  |  | 74,711 |  |  |  | 3,996,174 |
Notes receivable and advances (Note 4) |  |  | 913,754 |  |  |  | 10,313,754 |
Intangible assets, net (Note 6) |  |  | 23,962,994 |  |  |  | 24,943,388 |
Goodwill (Note 6) |  |  | 1,507,154 |  |  |  | 1,507,154 |
Finance lease - right of use asset, net (Note 8) |  |  | 18,927 |  |  |  | 836,921 |
Operating lease - right of use asset, net (Note 8) |  |  | 18,152,226 |  |  |  | 17,704,775 |
Other assets |  |  | 744,488 |  |  |  | 269,488 |
Total non-current assets |  |  | 141,166,005 |  |  |  | 148,946,658 |
TOTAL ASSETS |  | $ | 218,133,533 |  |  | $ | 169,604,637 |

The accompanying notes to the Condensed Consolidated Financial Statements are an integral part of these statements.

5

Table of Contents

COMSTOCK INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (Continued)

(UNAUDITED)

|  | March 31, 2026 |  |  | December 31, 2025 |
LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |  |  |  |  |  |
Current Liabilities: |  |  |  |  |  |  |  |
Accounts payable |  | $ | 3,283,958 |  |  | $ | 2,269,912 |
Accrued expenses and other liabilities (Note 7) |  |  | 3,726,467 |  |  |  | 4,848,299 |
Deferred revenue (Note 13) |  |  | 2,417,434 |  |  |  | 2,166,517 |
Liabilities held for sale (Note 5) |  |  | 6,651,319 |  |  |  | — |
Operating lease - right of use lease liability (Note 8) |  |  | 795,580 |  |  |  | 540,542 |
Deferred liabilities |  |  | 199,695 |  |  |  | 199,695 |
Total current liabilities |  |  | 17,074,453 |  |  |  | 10,024,965 |
Long-term Liabilities: |  |  |  |  |  |  |  |
Reclamation liability |  |  | 16,760 |  |  |  | 6,488,215 |
Finance lease - right of use lease liability (Note 8) |  |  | 17,039 |  |  |  | — |
Operating lease - right of use lease liability (Note 8) |  |  | 18,645,653 |  |  |  | 18,172,659 |
Deferred revenue (Note 7) |  |  | 1,870,830 |  |  |  | 1,887,500 |
Marathon Simple Agreement for Future Equity (“SAFE”) Note (Note 11) |  |  | 12,000,000 |  |  |  | 12,000,000 |
Flux Photon payable (Note 14) |  |  | 7,826,462 |  |  |  | 7,923,888 |
Other liabilities |  |  | 927,998 |  |  |  | 2,206,420 |
Total long-term liabilities |  |  | 41,304,742 |  |  |  | 48,678,682 |
TOTAL LIABILITIES |  |  | 58,379,195 |  |  |  | 58,703,647 |
COMMITMENTS AND CONTINGENCIES (Notes 9 and 14) |  |  |  |  |  |  |  |
Stockholders' Equity: |  |  |  |  |  |  |  |
Preferred stock $0.000666 par value, 50,000,000 shares authorized, no shares outstanding |  |  | — |  |  |  | — |
Common stock, $0.000666 par value, 245,000,000 shares authorized, 74,099,140 and 51,853,490 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively |  |  | 191,842 |  |  |  | 177,026 |
Additional paid-in capital |  |  | 544,352,401 |  |  |  | 486,130,452 |
Accumulated deficit |  |  | (388,110,925 | ) |  |  | (378,727,508 | )
Total equity - Comstock Inc. |  |  | 156,433,318 |  |  |  | 107,579,970 |
Non-controlling interest |  |  | 3,321,020 |  |  |  | 3,321,020 |
Total stockholders' equity |  |  | 159,754,338 |  |  |  | 110,900,990 |
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY |  | $ | 218,133,533 |  |  | $ | 169,604,637 |

The accompanying notes to the Condensed Consolidated Financial Statements are an integral part of these statements.

6

Table of Contents

COMSTOCK INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

|  | Three-Months Ended |
|  | March 31, |
|  | 2026 |  |  | 2025 |
Revenue |  | $ | 313,456 |  |  | $ | 785,815 |
Cost of goods sold |  |  | 599,810 |  |  |  | 886,796 |
Operating Expenses: |  |  |  |  |  |  |  |
Selling, general and administrative expenses |  |  | 6,568,773 |  |  |  | 3,258,465 |
Research and development |  |  | 2,096,242 |  |  |  | 3,303,918 |
Depreciation and amortization |  |  | 1,391,384 |  |  |  | 375,384 |
Gain on sale of royalty rights |  |  | (1,400,010 | ) |  |  | — |
Total operating expenses |  |  | 8,656,389 |  |  |  | 6,937,767 |
Loss from operations |  |  | (8,942,743 | ) |  |  | (7,038,748 | )
Other Income (Expense): |  |  |  |  |  |  |  |
Interest expense |  |  | (147,993 | ) |  |  | (659,144 | )
Interest income |  |  | 655,304 |  |  |  | 96,109 |
Change in fair value of derivative instruments |  |  | (722,015 | ) |  |  | (1,190,803 | )
Loss on conversion of debt |  |  | — |  |  |  | (1,196,880 | )
Gain on extinguishment of liability |  |  | — |  |  |  | 845,000 |
Other income (expense) |  |  | (225,970 | ) |  |  | 50,535 |
Total other income (expense), net |  |  | (440,674 | ) |  |  | (2,055,183 | )
Net loss |  |  | (9,383,417 | ) |  |  | (9,093,931 | )
Net loss attributable to noncontrolling interest |  |  | — |  |  |  | — |
Net loss attributable to Comstock Inc. |  | $ | (9,383,417 | ) |  | $ | (9,093,931 | )
Earnings per Share - Basic and Diluted: |  |  |  |  |  |  |  |
Net loss per share - basic and diluted |  | $ | (0.14 | ) |  | $ | (0.37 | )
Weighted average common shares outstanding, basic and diluted |  |  | 65,968,255 |  |  |  | 24,266,290 |

The accompanying notes to the Condensed Consolidated Financial Statements are an integral part of these statements.

7

Table of Contents

COMSTOCK INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

(UNAUDITED)

|  |  |  |  |  |  |  |  |  | Additional |  |  |  |  |  |  | Non- |  |  |  |  |
|  | Common Stock |  |  | Paid in |  |  | Accumulated |  |  | Controlling |  |  |  |  |
|  | Shares |  |  | Amount |  |  | Capital |  |  | Deficit |  |  | Interest |  |  | Total |
BALANCE - January 1, 2025 |  |  | 23,507,577 |  |  | $ | 156,590 |  |  | $ | 395,263,560 |  |  | $ | (335,651,065 | ) |  | $ | — |  |  | $ | 59,769,085 |
Common stock issuance costs |  |  | — |  |  |  | — |  |  |  | (145,000 | ) |  |  | — |  |  |  | — |  |  |  | (145,000 | )
Issuance of common stock for debt issuance costs |  |  | 110,059 |  |  |  | 733 |  |  |  | 531,182 |  |  |  | — |  |  |  | — |  |  |  | 531,915 |
Issuance of common stock for conversion of debt and accrued interest |  |  | 1,490,624 |  |  |  | 1,798 |  |  |  | 3,999,445 |  |  |  | — |  |  |  | — |  |  |  | 4,001,243 |
Issuance of common stock in lieu of payment of interest |  |  | 35,366 |  |  |  | 117 |  |  |  | 142,305 |  |  |  | — |  |  |  | — |  |  |  | 142,422 |
Adjustment for fractional shares in connection with reverse split |  |  | 246 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Issuance of common stock for AST lease amendment |  |  | 985,000 |  |  |  | 656 |  |  |  | 2,481,544 |  |  |  | — |  |  |  | — |  |  |  | 2,482,200 |
Issuance of common stock for LINICO acquisition-related payable |  |  | 775,000 |  |  |  | 516 |  |  |  | 1,859,484 |  |  |  | — |  |  |  | — |  |  |  | 1,860,000 |
Net loss |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (9,093,931 | ) |  |  | — |  |  |  | (9,093,931 | )
BALANCE - March 31, 2025 |  |  | 26,903,872 |  |  | $ | 160,410 |  |  | $ | 404,132,520 |  |  | $ | (344,744,996 | ) |  | $ | — |  |  | $ | 59,547,934 |
BALANCE - January 1, 2026 |  |  | 51,853,490 |  |  | $ | 177,026 |  |  | $ | 486,130,452 |  |  | $ | (378,727,508 | ) |  | $ | 3,321,020 |  |  | $ | 110,900,990 |
Issuance of common stock for cash |  |  | 21,781,929 |  |  |  | 14,507 |  |  |  | 60,964,674 |  |  |  | — |  |  |  | — |  |  |  | 60,979,181 |
Common stock issuance costs |  |  | — |  |  |  | — |  |  |  | (4,606,575 | ) |  |  | — |  |  |  | — |  |  |  | (4,606,575 | )
Issuance of common stock for director compensation |  |  | 463,721 |  |  |  | 309 |  |  |  | 1,863,850 |  |  |  | — |  |  |  | — |  |  |  | 1,864,159 |
Net loss |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (9,383,417 | ) |  |  | — |  |  |  | (9,383,417 | )
BALANCE - March 31, 2026 |  |  | 74,099,140 |  |  | $ | 191,842 |  |  | $ | 544,352,401 |  |  | $ | (388,110,925 | ) |  | $ | 3,321,020 |  |  | $ | 159,754,338 |

The accompanying notes to the Condensed Consolidated Financial Statements are an integral part of these statements.

8

Table of Contents

COMSTOCK INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

|  | Three-Months Ended |
|  | March 31, |
|  | 2026 |  |  | 2025 |
CASH FLOWS FROM OPERATING ACTIVITIES |  |  |  |  |  |  |  |
Net loss |  | $ | (9,383,417 | ) |  | $ | (9,093,931 | )
Adjustments to reconcile net loss to net cash used in operating activities: |  |  |  |  |  |  |  |
Depreciation and amortization |  |  | 1,378,574 |  |  |  | 365,659 |
Amortization of finance leases |  |  | 12,937 |  |  |  | 12,811 |
Accretion of interest |  |  | 147,273 |  |  |  | — |
Amortization of debt discount and other debt-related items |  |  | — |  |  |  | 214,298 |
Accretion of reclamation liability |  |  | 120,269 |  |  |  | 109,915 |
Interest expense paid with common stock |  |  | — |  |  |  | 142,422 |
Research and development expense paid with common stock |  |  | — |  |  |  | 1,487,476 |
Gain on extinguishment of liability |  |  | — |  |  |  | (845,000 | )
Loss on conversion of debt |  |  | — |  |  |  | 1,196,880 |
Director share-based compensation |  |  | 321,659 |  |  |  | — |
Change in fair value of derivative instruments |  |  | 722,015 |  |  |  | 1,190,803 |
Share of net (income) loss of equity-method investments |  |  | 251,844 |  |  |  | (41,438 | )
Other |  |  | (12,079 | ) |  |  | 175,943 |
Changes in operating assets and liabilities: |  |  |  |  |  |  |  |
Accounts receivable |  |  | 976,365 |  |  |  | (378,808 | )
Prepaid expenses |  |  | (362,808 | ) |  |  | (48,672 | )
Deposits |  |  | — |  |  |  | (60,000 | )
Other assets |  |  | 210,141 |  |  |  | (6,270 | )
Accounts payable |  |  | 1,017,380 |  |  |  | 339,379 |
Accrued expenses and other liabilities |  |  | (963,786 | ) |  |  | (606,943 | )
Deferred revenue |  |  | 250,917 |  |  |  | 757,958 |
Flux Photon payable |  |  | (480,000 | ) |  |  | — |
Other liabilities |  |  | (30,442 | ) |  |  | 125,000 |
Net cash used in operating activities |  |  | (5,823,158 | ) |  |  | (4,962,518 | )
CASH FLOWS FROM INVESTING ACTIVITIES: |  |  |  |  |  |  |  |
Deposits paid on equipment |  |  | (2,024,149 | ) |  |  | — |
Purchase of mineral rights and properties, plant and equipment |  |  | (5,676,932 | ) |  |  | (240,873 | )
Acquisition of intangible asset |  |  | — |  |  |  | (180,000 | )
Funding of RenFuel note receivable |  |  | — |  |  |  | (430,000 | )
Investment in Hexas SAFE Note |  |  | — |  |  |  | (366,667 | )
Advances in SSOF |  |  | (5,750,000 | ) |  |  | — |
Investment in SSOF |  |  | (2,000,000 | ) |  |  | (300,000 | )
Payments on contractual commitments associated with derivatives |  |  | (129,000 | ) |  |  | (120,000 | )
Proceeds received from contractual commitments associated with derivatives |  |  | 1,231,667 |  |  |  | — |
Payment of reclamation bond deposit |  |  | (150,000 | ) |  |  | (150,000 | )
Other |  |  | (34,122 | ) |  |  | (28,790 | )
Net cash used in investing activities |  |  | (14,532,536 | ) |  |  | (1,816,330 | )
CASH FLOWS FROM FINANCING ACTIVITIES: |  |  |  |  |  |  |  |
Proceeds from the issuance of common stock |  |  | 60,979,181 |  |  |  | — |
Issuances of debt |  |  | — |  |  |  | 10,000,000 |
Principal payments of debt |  |  | — |  |  |  | (100,000 | )
Common stock issuance costs |  |  | (4,606,575 | ) |  |  | (145,000 | )
Principal payments on financing leases |  |  | (756 | ) |  |  | (23,650 | )
Net cash provided by financing activities |  |  | 56,371,850 |  |  |  | 9,731,350 |
Net increase (decrease) in cash and cash equivalents |  |  | 36,016,156 |  |  |  | 2,952,502 |
Cash and cash equivalents at beginning of period |  |  | 16,951,645 |  |  |  | 954,271 |
Cash and cash equivalents at end of period |  | $ | 52,967,801 |  |  | $ | 3,906,773 |
NON-CASH INVESTING AND FINANCING ACTIVITIES: |  |  |  |  |  |  |  |
Issuance of common stock for director compensation |  | $ | 1,864,159 |  |  | $ | — |
SSOF advances converted to equity investment |  |  | 15,150,000 |  |  |  | — |
Deposits on equipment applied to property, plant and equipment |  |  | 7,465,610 |  |  |  | — |
Recognition of Great Basin guaranty asset and liability |  |  | 475,000 |  |  |  | — |
Recognition of operating lease liability and right of use asset |  |  | 698,863 |  |  |  | 3,548,557 |
Issuance of common shares for debt conversion and accrued interest |  |  | — |  |  |  | 4,001,243 |
Issuance of common stock for LINICO acquisition-related payable |  |  | — |  |  |  | 1,860,000 |
Issuance of common stock for AST lease amendment |  |  | — |  |  |  | 2,482,200 |
Acquisition of plant and equipment from Marathon SAFE Note |  |  | — |  |  |  | 12,000,000 |

The accompanying notes to the Condensed Consolidated Financial Statements are an integral part of these statements.

9

Table of Contents

COMSTOCK INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

BUSINESS AND REFERENCES TO THE COMPANY

Unless indicated, the terms we, us, our, Comstock, or the Company mean Comstock Inc., and its subsidiaries on a consolidated basis.

ORGANIZATION AND NATURE OF OPERATIONS

Comstock commercializes innovative technologies, systems and supply chains that extract, process, and convert under-utilized waste and natural resources into clean energy and clean energy supporting products, including truly sustainable solutions that produce renewed and repurposed electrification metals and minerals from end-of-life solar panels. Bioleum Corporation (“Bioleum”), the Company's subsidiary, seeks to commercialize technologies, systems and supply chains that produce renewable fuels from waste, purpose grown energy crops and other forms of woody biomass.

BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION

The condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and include the accounts of Comstock Inc. and its wholly owned and majority owned subsidiaries. All intercompany transactions have been eliminated. The condensed consolidated financial statements do not include all disclosures required of annual consolidated financial statements and, accordingly, should be read in conjunction with our consolidated financial statements and notes thereto in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Accordingly, operating results for the three-months ended March 31, 2026 may not be indicative of full year 2026 results.

In management's opinion, the accompanying condensed consolidated financial statements contain all adjustments necessary for a fair statement of our financial position as of March 31, 2026, and our results of operations, changes in equity and cash flows for the three-months ended March 31, 2026 and 2025.

GUARANTEES

The Company accounts for guarantees in accordance with ASC Topic 460, Guarantees. Guarantee obligations are recognized as liabilities at the time the guarantee is contractually executed and are initially measured at fair value, reflecting the Company’s noncontingent obligation to stand ready to perform under the guarantee. The guaranteed liability remains outstanding until the Company is released from its exposure under the guarantee, which generally occurs upon expiration or settlement of the guarantee.

LIQUIDITY AND CAPITAL RESOURCES

The condensed consolidated financial statements are prepared on the going concern basis of accounting that assumes the realization of assets and the satisfaction of liabilities in the ordinary course of business. The Company has had recurring net losses from operations and had an accumulated deficit of $388,110,925 at March 31, 2026. For the three-months ended March 31, 2026, the Company recognized a net loss of $9,383,417. Cash and cash equivalents increased by $36,016,156 from $16,951,645 at December 31, 2025 to $52,967,801 at March 31, 2026. At March 31, 2026, the Company has no outstanding debt. The Company intends to fund our operations over the next twelve months from existing cash and cash equivalents, planned sales of non-strategic assets and other investments, sales and deferred revenue from our solar panel recycling business, and issuance of subsidiary-level equity (that is, by Bioleum Corporation). The Company also maintains access to capital from our existing shelf registration statement. Based on these existing and expected funding sources, management believes we will have sufficient funds to sustain our operations and meet our commitments under our investment agreements during the 12 months following the date of issuance of the consolidated financial statements included herein.

RECLASSIFICATIONS

Certain prior period amounts have been reclassified to conform to the 2026 financial statement presentation. Reclassifications had no effect on net income (loss), cash flows, or stockholders' equity as previously reported.

RECENTLY ISSUED ACCOUNTING STANDARDS

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires disclosure about the types of costs and expenses included in certain expense captions presented on the income statement. The new disclosure requirements are effective for the Company's annual periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with early adoption permitted, and may be applied either prospectively or retrospectively. The Company is currently evaluating the ASU to determine its impact on our consolidated financial statements and disclosures.

Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

10

Table of Contents

NOTE 2 ACQUISITION OF HEXAS BIOMASS INC.

On December 4, 2025, the Company's majority-owned subsidiary, Bioleum, and the Hexas shareholders entered into a Stock Purchase Agreement to acquire 100% of the issued and outstanding equity and voting shares of Hexas. For the three-months ended March 31, 2026, Hexas recognized no revenue and incurred a loss of $97,556.

The pro forma financial information below represents the combined results of operations. For the three-months ended March 31, 2025, as if the acquisition had occurred on January 1, 2025. The pro forma financial information is presented for informational purposes only and is neither indicative of the results of operations that would have occurred if the acquisition had taken place at the beginning of the period presented nor indicative of future operating results.

|  | March 31, 2025 |
Revenue |  | $ | 785,815 |
Net loss |  | $ | (9,324,108 | )

NOTE 3 INVESTMENTS

At March 31, 2026 and December 31, 2025, our investments include:

|  | March 31, 2026 |  |  | December 31, 2025 |
Equity Method Investments: |  | Investment |  |  | Ownership % |  |  | Investment |  |  | Ownership % |
Investment in research and development company |  | $ | 1,055,371 |  |  |  | 40.00 | % |  | $ | 1,079,371 |  |  |  | 40.00 | %
Sierra Springs Opportunity Fund, Inc. |  |  | 37,147,156 |  |  |  | 40.66 | % |  |  | 20,225,000 |  |  |  | 16.99 | %
Total equity method investments |  |  | 38,202,527 |  |  |  |  |  |  |  | 21,304,371 |  |  |  |  |
Measurement Alternative Investments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Green Li-ion Pte. Ltd. |  |  | 18,201,065 |  |  |  | 13.34 | % |  |  | 18,201,065 |  |  |  | 13.34 | %
Total measurement alternative investments |  |  | 18,201,065 |  |  |  |  |  |  |  | 18,201,065 |  |  |  |  |
Total Investments |  | $ | 56,403,592 |  |  |  |  |  |  | $ | 39,505,436 |  |  |  |  |

Summary financial information for affiliated companies accounted for by the equity method for the periods presented, compiled from the equity investee's financial statements and reported on a one quarter lag is as follows:

|  | Three-Months Ended |
|  | March 31, 2026 |  |  | March 31, 2025 |
Revenues |  | $ | 121,910 |  |  | $ | 350,700 |
Gross Profit |  | $ | 106,823 |  |  | $ | - |
Net income (loss) |  | $ | (620,364 | ) |  | $ | 103,595 |
Net income (loss) attributable to Comstock Inc. |  | $ | (251,844 | ) |  | $ | 41,438 |

Investment in Research and Development Company

On March 1, 2024, the Company entered into a Securities Purchase Agreement (the “Developer Securities Purchase Agreement”) with an unaffiliated research and development company (“Developer”) and recognized an initial investment of $1,290,614. Concurrently and in connection with entering into the Developer Securities Purchase Agreement, the Company and Developer entered into a Development Services Agreement (“DSA”) for purposes of conducting certain research and development work (see Note 9).

At March 31, 2026, the future remaining payments, net implied interest, totaled $1,284,022 (see Note 7). For the three-months ended March 31, 2026, the Company recorded $24,000 in equity loss from affiliates for our investment in the Developer. For the three-months ended March 31, 2025, the Company recognized $41,438 in equity income from affiliates for our investment in the Developer. During the three-months ended March 31, 2026 and 2025, the Company paid $0 to the Developer in accordance with the funding commitments under the Developer Securities Purchase Agreement.

11

Table of Contents

Investment in Sierra Springs Opportunity Fund Inc. (“SSOF”)

From 2019 through December 31, 2025, the Company invested $8,500,000 for 11,236,111 shares in SSOF resulting in equity ownership of 16.99% as of December 31, 2025. The December 31, 2025 carrying value of the Company's investment in SSOF reflects an observable transaction adjustment recorded by the Company in 2023. For the three-months ended March 31, 2026, the Company recognized $227,844 in equity loss from affiliates for our investment in SSOF.
At December 31, 2025, the Company had an advance to SSOF of $9,400,000. During the three-months ended March 31, 2026, the Company advanced an additional $5,750,000. On March 26, 2026, all advances, totaling $15,150,000 were contributed in exchange for 23,307,692 shares of SSOF common stock at $0.65 per share. On March 30, 2026, the Company subscribed to and invested an additional $2,000,000 for 3,076,923 additional shares of SSOF common stock, also at $0.65 per share. These investments increased the Company's ownership to 40.66%. At March 31, 2026 and December 31, 2025, the Company owns 37,620,726 and 11,236,111, respectively, in SSOF shares of common stock, representing an ownership of 40.66% and 16.99%, respectively.
In connection with the change in ownership, management reassessed its prior conclusions regarding the Company's variable interest in SSOF. SSOF continues to be a variable interest entity in which the Company holds a variable interest, and the Company continues to conclude that it is not the primary beneficiary of SSOF, because the Company does not have the power, individually or together with its related parties, to direct the activities of SSOF that most significantly affect SSOF's economic performance. Although the Company's chief executive officer also serves as an executive of SSOF, this relationship was previously evaluated and was a factor in the prior conclusion, which remains unchanged. Accordingly, SSOF is not consolidated, and the Company accounts for its investment in SSOF under the equity method. At March 31, 2026, the Company's maximum exposure to loss as a result of its involvement with SSOF is limited to its investment of $ 37,147,156.
Investment in Green Li-ion Pte. LTD ( “ Green Li-ion ” )
At March 31, 2026 and December 31, 2025, the Company owned 35,662 Green Li-ion preferred shares and our ownership remained at 13.34%. The Company monitors additional equity issuances and other potential orderly transactions of Green Li-ion to assess whether the equity securities issued are similar investments requiring adjustments of our investments carrying value to fair value. During the three-months ended March 31, 2026 and 2025, no adjustments were made to the carrying value of our investment in Green Li-ion as no orderly transactions for investments similar to the Company's investment were observed during those periods.

NOTE 4 NOTES RECEIVABLE AND ADVANCES

Notes receivable and advances at March 31, 2026 and December 31, 2025 include:

|  | March 31, 2026 |  |  | December 31, 2025 |
Sierra Springs advances receivable |  | $ | — |  |  | $ | 9,400,000 |
Daney Ranch note receivable |  |  | 913,754 |  |  |  | 913,754 |
Total notes receivable and advances |  | $ | 913,754 |  |  | $ | 10,313,754 |

Advances to Sierra Springs Opportunity Fund, Inc.

At December 31, 2025, the Company had an advance to SSOF of $9,400,000. During the three-months ended March 31, 2026, the Company advanced an additional $5,750,000. On March 26, 2026, all advances, totaling $15,150,000 were contributed in exchange for 23,307,692 shares of SSOF common stock at $0.65 per share. On March 30, 2026, the Company subscribed to and invested an additional $2,000,000 for 3,076,923 additional shares of SSOF common stock, also at $0.65 per share. These investments increased the Company's ownership to 40.66% (see Note 3). Total advances outstanding at March 31, 2026 and December 31, 2025 were $0 and $9,400,000, respectively. The advances were unsecured and bore interest at 4.5%. At March 31, 2026 and December 31, 2025, interest receivable on the advances is $237,415 and $0, respectively, and is included in prepaid expenses and other current assets on our condensed consolidated balance sheet.

NOTE 5 PROPERTIES, PLANT AND EQUIPMENT, NET AND MINERAL RIGHTS

Properties, plant and equipment at March 31, 2026 and December 31, 2025 include the following:

|  | March 31, 2026 |  |  | December 31, 2025 |
Land |  | $ | 6,329,338 |  |  | $ | 8,529,338 |
Real property leased to third parties |  |  | 79,030 |  |  |  | 1,037,049 |
Property, plant and equipment for mineral processing |  |  | — |  |  |  | 27,241,814 |
Property, plant and equipment for renewable fuels processing |  |  | 13,724,303 |  |  |  | 12,881,458 |
Property, plant and equipment for solar panel recycling |  |  | 3,123,974 |  |  |  | 3,123,974 |
Construction in process |  |  | 14,712,022 |  |  |  | 1,588,214 |
Other property and equipment |  |  | 4,032,150 |  |  |  | 4,429,933 |
Accumulated depreciation |  |  | (5,904,437 | ) |  |  | (28,945,571 | )
Total properties, plant and equipment, net |  | $ | 36,096,380 |  |  | $ | 29,886,209 |

During the three-months ended March 31, 2026 and 2025, the Company recognized depreciation expense of $402,766 and $147,680, respectively. At March 31, 2026 and December 31, 2025, the Company had $14,712,022 and $1,817,503, respectively, primarily for construction work in process that were not yet placed in service and have not yet begun depreciating.

The Company entered into purchase order commitments with third party vendors for equipment to be used in our industry-scale solar panel recycling facility to recycle and process end-of-life solar panels. As of March 31, 2026 and December 31, 2025, the Company recorded $2.1 million and $7.6 million, respectively, in advances to vendors for equipment purchases within deposits on our condensed consolidated balance sheet.

12

Table of Contents

Mineral Rights and Properties

Our mineral rights and properties at March 31, 2026 and December 31, 2025 consisted of the following:

|  | March 31, 2026 |  |  | December 31, 2025 |
Comstock Mineral Estate |  | $ | — |  |  | $ | 10,842,716 |
Other mineral properties |  |  | — |  |  |  | 317,405 |
Water rights |  |  | 730,597 |  |  |  | 820,595 |
Total mineral rights and properties |  | $ | 730,597 |  |  | $ | 11,980,716 |

The Comstock Mineral Estate includes all of the Company's resource areas and exploration targets. During the three-months ended March 31, 2026 and 2025, we did not record any depletion expense, as none of the mineral properties are currently in production. Our mineral exploration and mining lease payments are classified as selling, general and administrative expenses in the condensed consolidated statements of operations.

On December 18, 2024 and amended on June 6, 2025, the Company executed a membership interest purchase agreement (the “Mackay MIPA”) with Mackay Precious Metals Inc. (“Mackay”) pursuant to which the Company sold all of its right, title, and interest in its wholly owned subsidiary Comstock Northern Exploration LLC, and the Company's 25% interest in Pelen Limited Liability Company (“Pelen”), for an aggregate purchase price of $2,950,000. Pursuant to a royalty agreement between the Company and Mackay, dated December 18, 2024 (the “Mackay Royalty Agreement”) the Company was to receive a 1.5% royalty of Net Smelter Returns (as such term is defined in the Mackay Royalty Agreement). On January 9, 2026, the Company and Mackay entered into a Royalty Purchase and Sale Agreement, wherein the Company sold to Mackay 100% of the Company’s right, title, and interest in and to a 1.5% net smelter returns royalty covering certain patented and unpatented mining claims and leased properties located in Storey County, Nevada, for an aggregate purchase price of $1,100,000, all of which was received on or before January 20, 2026. On February 22, 2026, the Company agreed to a minor modification to the non-compete language associated with the prior purchase of properties by Mackay and received an additional $300,000 in consideration from Mackay. During the three-months ended March 31, 2026, the Company recognized a total gain on sale of royalty rights of $1,400,010 in the condensed consolidated statements of operations.

Assets and Liabilities Held for Sale

In the first quarter of 2026, the Company committed a plan to sell the mining assets and related mining entities. The related assets and liabilities were classified as Held for Sale and $22,732,293 was classified as Assets Held for Sale and $6,651,319 was classified as Liabilities Held for Sale on the condensed consolidated balance sheet as of March 31, 2026.

The Company’s assets and liabilities held for sale at March 31, 2026, include the following:

Assets held for sale |  | March 31, 2026 |
Mineral properties |  | $ | 11,160,121 |
Water rights |  |  | 90,000 |
Buildings, land and equipment, net |  |  | 7,353,714 |
Reclamation bond deposit |  |  | 4,105,585 |
Other |  |  | 22,873 |
Total assets held for sale |  | $ | 22,732,293 |

Liabilities held for sale |  | March 31, 2026 |
Reclamation liability |  | $ | 6,591,724 |
Other |  |  | 59,595 |
Total liabilities held for sale |  | $ | 6,651,319 |

NOTE 6 INTANGIBLE ASSETS AND GOODWILL

The Company’s intangible assets at March 31, 2026 and December 31, 2025 include the following:

|  | Estimated |  |  |  |  |  |  |  |  |
|  | Economic Life |  |  |  |  |  |  |  |  |
Description |  | (in years) |  |  | March 31, 2026 |  |  | December 31, 2025 |
Developed technologies |  | 10 |  |  | $ | 29,780,018 |  |  | $ | 29,780,018 |
License agreements |  | 10 |  |  |  | 499,952 |  |  |  | 499,952 |
Distribution agreements |  | 8 |  |  |  | 19,733 |  |  |  | 19,733 |
Accumulated amortization |  |  |  |  |  | (6,336,709 | ) |  |  | (5,356,315 | )
Intangible assets, net |  |  |  |  | $ | 23,962,994 |  |  | $ | 24,943,388 |

Accumulated amortization as of March 31, 2026 and December 31, 2025 consisted of the following:

|  | March 31, 2026 |  |  | December 31, 2025 |
Developed technologies |  | $ | 6,084,327 |  |  | $ | 5,116,765 |
License agreements |  |  | 238,146 |  |  |  | 226,063 |
Distribution agreements |  |  | 14,236 |  |  |  | 13,487 |
Accumulated amortization |  | $ | 6,336,709 |  |  | $ | 5,356,315 |

13

Table of Contents

For the three-months ended March 31, 2026 and 2025, amortization expense related to intangible assets was $980,394 and $217,978, respectively.

Future minimum amortization expense is as follows at March 31, 2026:

Remainder of 2026 |  | $ | 2,941,185 |
2027 |  |  | 3,921,579 |
2028 |  |  | 3,918,834 |
2029 |  |  | 3,918,582 |
2030 |  |  | 3,918,582 |
Thereafter |  |  | 5,344,232 |
|  | $ | 23,962,994 |

Changes in the intangible assets and goodwill balances for the three-months ended March 31, 2026 and 2025, are presented below:

|  | As of December 31, 2025 |  |  | Additions |  |  | Impairment |  |  | Amortization |  |  | As of March 31, 2026 |
Intangible assets |  | $ | 30,299,703 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 30,299,703 |
Accumulated amortization |  |  | (5,356,315 | ) |  |  | — |  |  |  | — |  |  |  | (980,394 | ) |  |  | (6,336,709 | )
Goodwill |  |  | 1,507,154 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1,507,154 |
Total intangible assets and goodwill |  | $ | 26,450,542 |  |  | $ | — |  |  | $ | — |  |  | $ | (980,394 | ) |  | $ | 25,470,148 |

|  | As of December 31, 2024 |  |  | Additions |  |  | Impairment |  |  | Amortization |  |  | As of March 31, 2025 |
Intangible assets |  | $ | 8,706,972 |  |  | $ | 180,000 |  |  | $ | — |  |  | $ | — |  |  | $ | 8,886,972 |
Accumulated amortization |  |  | (2,847,820 | ) |  |  | — |  |  |  | — |  |  |  | (217,978 | ) |  |  | (3,065,798 | )
Total intangible assets |  | $ | 5,859,152 |  |  | $ | 180,000 |  |  | $ | — |  |  | $ | (217,978 | ) |  | $ | 5,821,174 |

All intangibles and goodwill are associated with our Fuels Segment.

NOTE 7 ACCRUED EXPENSES AND OTHER LIABILITIES - CURRENT

Accrued expenses and other liabilities - current at March 31, 2026 and December 31, 2025 consisted of the following:

|  | March 31, 2026 |  |  | December 31, 2025 |
Accrued payroll costs |  | $ | 1,068,187 |  |  | $ | 1,501,110 |
Accrued incentive compensation |  |  | — |  |  |  | 263,750 |
Accrued vendor liabilities |  |  | 460,281 |  |  |  | 753,221 |
Payable to research and development company - current |  |  | 1,284,022 |  |  |  | 1,146,845 |
Payable to Flux Photon - current (see Note 14) |  |  | 877,629 |  |  |  | 1,143,412 |
Other accrued expenses |  |  | 36,348 |  |  |  | 39,961 |
Total accrued expenses |  | $ | 3,726,467 |  |  | $ | 4,848,299 |

Payable to Research and Development Company

As of March 31, 2026, the short-term payable to a research and development company (“Developer”) of $1,284,022 consists of payments due under the Securities Purchase Agreement dated March 1, 2024, between the Company and the Developer (see Note 3). During the three-months ended March 31, 2026 and 2025, the Company paid $0 to the Developer in accordance with the funding commitments under the Developer Securities Purchase Agreement. For the three-months ended March 31, 2026 and 2025, the Company recognized interest expense of $29,852, which represents the amortization of the discount that was recognized on the date of the agreement since the payable associated with the funding commitment is non-interest bearing.

Oklahoma Grant

On December 11, 2024, the Company was granted an award of $3,000,000 (the “OKL Award”), pursuant to that Contract between the Oklahoma Department of Commerce and the Company for a contractual award from the Oklahoma Quick Action Closing Fund (the “Contract”). The OKL Award funds in three tranches of $1,000,000 each within 45 days of Comstock Fuels Corporation (“Comstock Fuels”), a wholly owned subsidiary of the Company, meeting these three conditions:

• | publicly announcing the relocation of the Comstock Fuels headquarters to Oklahoma, which was completed in the first quarter of 2025;

• | identifying an Oklahoma site for the construction of a next-generation renewable fuel refinery and securing that site; and

• | invests at least $5,000,000 towards engineering, machinery, and/or materials associated with that Oklahoma site/facility.

The OKL Award must be used for purposes of economic development and related infrastructure development. The Award requires certain ongoing conditions to be met, including without limitation, creation of 45 jobs, with an average salary of $80,000 per person, $160 million of total investments, maintenance of headquarters by March 31, 2026, with at least ten jobs for a period of at least ten consecutive quarters no later than December 31, 2030, and operation of a commercial demonstration biorefinery no later than December 31, 2031, otherwise the granted monies received would have to be repaid. In 2025, the Company met the first and second conditions of the OKL Award. On January 20, 2026, the Company received $1,000,000 from the Oklahoma Department of Commerce for the second condition of the OKL Award. For the three-months ended March 31, 2026 and 2025, the Company recognized grant income of $16,670 and $8,333, respectively, in other income (expense) in the condensed consolidated statement of operations and recorded deferred revenue of $66,666 in accrued expenses and other liabilities and $1,870,830 in long-term deferred revenue on the condensed consolidated balance sheet. As of March 31, 2026 and December 31, 2025, the Company recorded $0 and $1,000,000, respectively, in accounts receivable on the condensed consolidated financial statements.

14

Table of Contents

NOTE 8 LEASES

The Company has the following lease expense recognized in the condensed consolidated statements of operations as follows:

|  | Three-Months Ended |
|  | March 31, 2026 |  |  | March 31, 2025 |
Finance lease expense: |  |  |  |  |  |  |  |
Amortization of right-of-use assets |  | $ | 12,937 |  |  | $ | 12,811 |
Interest on lease liabilities |  |  | 629 |  |  |  | — |
Operating lease expense |  |  | 828,541 |  |  |  | 297,748 |
Total lease expense |  | $ | 842,107 |  |  | $ | 310,559 |
Other information: |  |  |  |  |  |  |  |
Operating cash flows used in operating leases |  | $ | 545,571 |  |  | $ | 161,232 |
Short-term operating lease expense |  | $ | 15,824 |  |  | $ | 29,594 |

The Company has the following weighted average remaining lease terms and discount rates for our finance and operating leases:

|  | March 31, 2026 |  |  | March 31, 2025 |
Weighted-average remaining lease term - finance leases (years) |  |  | 4.50 |  |  |  | — |
Weighted-average remaining lease term - operating leases (years) |  |  | 22.98 |  |  |  | 10.34 |
Weighted-average discount rate - finance leases |  |  | 39.6 | % |  |  | — | %
Weighted-average discount rate - operating leases |  |  | 13.3 | % |  |  | 13.5 | %

Finance Lease

Navitas

On March 11, 2026, the Company, as lessee, signed an Equipment Lease Agreement (the “Equipment Lease Agreement”) with lessor to lease security system equipment located at 600 Lake Avenue, Silver Springs, NV. The Equipment Lease Agreement is under a fifty-five month term commencing on March 15, 2026 at $756 per month. At lease inception, the Equipment Lease Agreement was classified as a finance lease with a lease term of fifty-five months, which exceeds 75% of the useful life of the equipment. On March 15, 2026, the Company recorded a right-of-use asset and lease liability of $19,053 at an implicit discount rate of 39.63%. For the three months ended March 31, 2026, the amortization of right-of-use asset and interest expense was $756.

Operating Leases

Comstock Metals

On December 10, 2025, the Company, as lessee, signed a Lease Agreement (the “Industrial and Commercial Lease”) with the lessor to lease land and premises located at 10210 Idaho Ave, Hanford, CA. Under the Industrial and Commercial Lease, rent payments of $17,500 per month will begin when all necessary and required permits are secured. In February 2026 all required permits were secured which resulted in an increase in the right-of-use asset and lease liability of $19,449. For the three months ended March 31, 2026, the fixed operating lease expense was $57,021.

15

Table of Contents

On January 1, 2026, the Company, as lessee, signed a Lease Agreement (the “Lease Agreement”) with lessor to lease land and premises located at 60901 Beech Grove Lane, Cambridge, OH. The Lease Agreement is under a five-year term commencing on January 1, 2026, or upon receipt of all required permits, and includes an option to extend the term for an additional 60 months with rental expense of $12,500 per month. Lease payments under the Lease Agreement do not begin until all permits are received, which occurred in March 2026. At lease inception, the Lease Agreement was classified as an operating lease with a lease term of five years. At January 1, 2026, the Company recorded a right-of-use asset and lease liability of $523,890 at an implicit discount rate of 14.08%. For the three months ended March 31, 2026, the fixed operating lease expense was $36,290.

On March 1, 2026, the Company assumed an existing lease with Ren Fuel K2B Snowco AB, as lessee, for hydrotreating equipment with lessor. The Lease Agreement (the “Hydrotreating Equipment Lease”) had an original lease term of five years commencing on June 2, 2024. Under the lease, rental expense is $6,178 per month. The lease automatically renews at the end of the five-year period, unless notice of cancellation is given three months prior to the end of the original term. The Company currently does not believe an extension beyond the original term is probable. At lease inception, the Hydrotreating Equipment Lease was classified as an operating lease with a remaining lease term of 3.3 years. The interest rate explicit in the lease is the 90-day Stockholm Interbank Offering Rate (STIBOR). At March 1, 2026, the Company recorded a right-of-use asset and lease liability of $238,379 at a discount rate of 2.12%. For the three months ended March 31, 2026, the fixed operating lease expenses were $6,178.

Sierra Clean Processing LLC (“SCP”)

On August 15, 2023, the Company, as lessee, signed a Real Estate and Building Lease Agreement with SCP to lease real property and improvements located at 700 Lake Avenue in Silver Springs, Nevada. For the three-months ended March 31, 2026 and 2025, the fixed operating lease expense was $14,908.

On July 1, 2024, the Company, as lessee, signed a Real Estate and Building Lease Agreement (the “SCP Real Estate and Building Lease”) with SCP to lease real property and improvements located at 600 Lake Avenue in Silver Springs, Nevada. Under the SCP Real Estate and Building Lease, rent payments were $30,000 per month until all necessary and required permits were secured. In February 2026 all required permits were secured which resulted in a decrease in the right-of-use asset and lease liability of $73,792. For the three-months ended March 31, 2026 and 2025, the fixed operating lease expense was $215,254 and $217,875, respectively.

On November 1, 2025, the Company, as lessee, signed a Lease Agreement (the “SCP Storage Lease”) with SCP to lease land and premises located at 800 Lake Avenue in Silver Springs, Nevada. Under the SCP Storage Lease, rent payments of $5,000 per month will begin when all necessary and required permits are secured which occurred during the quarter ended March 31, 2026, and resulted in a decrease in the right-of-use asset and lease liability of $28,116. For the three months ended March 31, 2026, the fixed operating lease expense was $14,212.

The Company's chief executive officer is an executive and director of SCP.

Minimum lease payments to be paid by the Company by fiscal year for the Company's operating leases are as follows:

|  |  | Operating Leases |  |  | Finance Leases |
For the remainder of 2026 |  |  | $ | 2,292,761 |  |  | $ | 6,802 |
2027 |  |  |  | 3,402,293 |  |  |  | 9,069 |
2028 |  |  |  | 3,343,160 |  |  |  | 9,069 |
2029 |  |  |  | 3,291,745 |  |  |  | 9,069 |
2030 |  |  |  | 3,203,672 |  |  |  | 6,802 |
Thereafter |  |  |  | 38,940,853 |  |  |  | — |
Total lease payments |  |  |  | 54,474,484 |  |  |  | 40,811 |
Less: imputed interest |  |  |  | (35,033,251 | ) |  |  | (21,884 | )
Present value of lease liabilities |  |  | $ | 19,441,233 |  |  | $ | 18,927 |

16

Table of Contents

NOTE 9 COMMITMENTS AND CONTINGENCIES

AST LICENSE AGREEMENTS

The Company is party to three license agreements (collectively, the “AST License Agreements”) with AST, pursuant to which the Company agreed to license certain developed technologies of AST for use at three facilities in exchange for three facility-specific license fees of $500,000 each, and a royalty fee equal to 1.0% of the gross revenue of each of the first three operating facilities. License fees totaling $1,500,000 for the AST licenses were completed in 2022, and no additional payments are anticipated. As of March 31, 2026, no royalty fees have been paid under the AST License Agreements.

GREAT BASIN PRECEDENT AGREEMENT

On November 29, 2025, the Company and Great Basin Gas Transmission Company (“Great Basin”) entered into a Precedent Agreement for Great Basin to construct and install pipelines and appurtenant facilities (“Expansion Facilities”) to our properties in Silver Springs Nevada and anticipated to be completed by November 2028. Upon approval of the certificate of public convenience by the Federal Energy Regulatory Commission (“FERC”) authorizing the construction of the Expansion Facilities and prior to commencing construction, Great Basin will tender a Transportation Service Agreement consistent with tariff for rate schedule to the Company. The Transportation Service Agreement will be for a term of twenty years beginning on November 1, 2028 with a daily reserve capacity of 50,000 Dekatherm. Great Basin may terminate the Precedent Agreement at any time if (1) Great Basin determines that all or any portion of the Expansion Facilities would be operationally and/or economically infeasible; (2) the Company fails to perform its duties and obligations; and (3) Great Basin has not received and accepted a final certificate order from FERC. If the Precedent Agreement is terminated, the Company must reimburse Great Basin all project development and default costs.

Under the Precedent Agreement and a related guaranty executed on March 31, 2026 (the “Great Basin Guaranty”), the Company has guaranteed the performance of its obligations, including potential reimbursement of its proportionate share of certain project development costs, in the event of specified termination or default events outside of the Company's control. To secure its obligations under the Great Basin Guaranty, the Company is required to provide credit support in the form of a phased surety arrangement, which is collateralized through an escrow account. The surety amount increases over time and is expected to reach approximately $54.0 million by December 31, 2027. The surety remains in effect until modified by Great Basin based on the Company’s payment history and creditworthiness or until the project reaches its in‑service date. The Company recognized a guarantee liability related to the Great Basin Guaranty, which was initially measured at fair value at the time the guaranty was executed. As of March 31, 2026, the carrying amount of the guarantee liability was $475,000, which is included in other long‑term liabilities in the condensed consolidated balance sheets. The corresponding guarantee asset is included in long-term other assets (see Note 11).

INVESTMENT IN LICENSED TECHNOLOGY

Developer (see Note 3)

On March 1, 2024, the Company and Developer entered into the DSA to advance technologies owned by the Company's subsidiary that incorporate applications of intellectual properties owned by the Developer (“Developer IP”) (See Note 3). For the three-months ended March 31, 2026 and 2025, the Company recorded $0 and $350,700, respectively, as research and development expense in the condensed consolidated statements of operations. On March 1, 2024, Developer granted the Company an exclusive license to use Developer IP to produce fuel (“Fuels License”) and treat water (“Water License” and, together with the Fuels License, the “Comstock License Agreements”) in exchange for royalty fees based on the production and sales of qualified products. The Comstock License Agreements also require the Company to pay minimum royalty fees equal to $20,000 on the earlier to occur of 240 days after receiving a patent for the Developer IP, and, commenced on February 15, 2025, and for each year thereafter, (i) $10,000 in years 1 and 2, (ii) $25,000 in years 3 and 4, and (iii) $75,000 in year 5 and thereafter. The Company also agreed to pay for certain outstanding and future patent costs, as well as a new patent filing fees for each new patent application added to the Licensed Patent Rights deriving from Developer individually ($10,000) or together with the Company ($5,000). The scope of the Water License is exclusive unless Comstock elects not to invest a minimum of $100,000 per calendar quarter after completion of Phase 1. As of March 31, 2026 and December 31, 2025, payables to the Developer included in accounts payable on the condensed consolidated balance sheet were $1,332,099.

NREL

On October 1, 2024, the Company entered into an agreement with a managing and operating contractor of the U.S. Department of Energy’s (“DOE”) National Renewable Energy Laboratory (“NREL”). The agreement provides that the Company fund the research which includes the use of its pilot facility, equipment and laboratory in Wisconsin. The ongoing funding commitment during 2026, and 2027 is $1.7 million and $1.5 million, respectively. In 2025, the company funded $1,616,928 for the funding commitment. For the three-months ended March 31, 2026 and 2025, $494,232 and $404,232, respectively, has been funded under the agreement and recognized as research and development expense.

On October 1, 2024, the Company entered into an exclusive licensing agreement with the same party whereby the Company obtained exclusive license in existing or future patent rights associated with the research. Under this licensing agreement, the Company will pay a royalty fee equal to 3% of net sales. The agreement includes minimum annual royalty payments that are not applied against future years’ royalty payments. For the three-months ended March 31, 2026 and 2025, the Company paid $90,000 and $65,000, respectively, in annual royalty fees recognized as research and development expense in our condensed consolidated statement of operations. Annual royalty payments are as follows:

|  | Minimum Annual Royalty |
For the remainder of 2026 |  | $ | - |
2027 |  | $ | 95,000 |
2028 |  | $ | 125,000 |
2029 |  | $ | 135,000 |
2030 |  | $ | 150,000 |
Thereafter |  | $ | 150,000 |

The Company has sublicensing rights and will pay a royalty fee equal to 15% of any such sublicensing revenue to NREL. The royalty fee and the sublicensing fee will be reduced to 2% and 10%, respectively, upon achievement of certain thresholds.

17

Table of Contents

Marathon Petroleum Corporation

On February 28, 2025, Bioleum, a subsidiary of the Company, entered into a series of definitive agreements with Virent Inc. (“Virent”), which have been assigned to Bioleum and involve the purchase of $14.0 million in Bioleum equity as part of Bioleum’s planned Series A preferred equity financing (“Series A Financing”), subject to a $700 million valuation cap (“Investment”). The purchase price included $1.0 million in cash and $13.0 million in the Marathon SAFE Note (see Note 11) issued in exchange for payment-in-kind assets, on and subject to the terms and conditions of the applicable transaction documents (“Investment Agreements”). The Investment Agreements, as amended on September 26, 2025, required the $1.0 million cash portion of the Investment to be made within five business days of the execution by Bioleum of third-party investment agreements for at least $25,000,000 in Series A equity financing. The Investment Agreements additionally required Bioleum to grant MPC Investment LLC a lien on the Marathon Payment-In Kind Assets if Bioleum does not complete $25,000,000 in the Series A equity financing before March 31, 2026. In the first quarter of 2026, Virent notified the Company that the $1.0 million in addition cash investment would not be extended and no lien on the Marathon Payment-In Kind Assets would be executed. As of March 31, 2026 and December 31, 2025, $20.0 million of Series A equity financing has been completed. The Investment Agreements provided for the grant by Virent to Bioleum of a non-exclusive, non-transferable, non-assignable, non-sublicensable, perpetual, royalty-free license under the Virent IP solely for research and development purposes associated with the Marathon Payment-In Kind (“Virent IP”), excluding applications involving the heterogenous catalysis of biomass-derived sugars.

OTHER

The Company agreed to pay each of the independent directors a total of $160,000 annually, in cash or shares of common stock, which includes an annual cash payment of $60,000 plus chair and committee meeting fees. The Chair of each Committee is paid an additional cash payment of $20,000 annually. For the three-months ended March 31, 2026 and 2025, the Company recognized director fees expenses of $396,658 and $200,000, respectively. As of March 31, 2026 and December 31, 2025, director fees compensation included in accounts payable on the condensed consolidated balance sheet was $0 and $290,000, respectively. From 2023 through 2025, the Company accrued $1,475,000 in director fee compensation associated with the director fees payable expected to be satisfied with shares of the Company's common stock and included in other long-term liabilities on the condensed consolidated balance sheet. In January 2026, the Company issued shares of stock to these directors to satisfy the amount accrued as of December 31, 2025 (see Note 10).

From time to time, we are involved in claims and proceedings that arise in the ordinary course of business. There are no matters pending that we expect to have a material adverse impact on our business, results of operations, financial condition or cash flows.

NOTE 10 EQUITY

Issuance of Registered Shares of Common Stock

2026 Issuances - For the three months ended March 31, 2026

On January 28, 2026, the Company announced a Confidentially Marketed Public Offering (“CMPO”) with Titan Partners Group LLC (“Titan Partners”). The Company raised $50 million in gross proceeds before underwriting discounts and commissions and other offering expenses. On January 30, 2026, the Company issued 18,181,819 registered shares of its common stock at a price of $2.75 per share for $50,000,002 and received net proceeds of $46,140,002 pursuant to the equity offering on January 28, 2026. On March 3, 2026, Titan Partners exercised their over-allotment option and placed an additional 2,727,272 registered shares of our common stock at a price of $2.75 per share for additional gross proceeds of $7,499,998 (net proceeds of $6,937,498).

On January 5, 2026, the Company issued a total of 463,721 shares of common stock of the Company with a fair value of $1,864,159 determined by the closing price per share of our common stock of $4.02 to our non-employee directors for annual director services for the period from January 1, 2022 and forward through March 31, 2026, pursuant to the shareholder approved Comstock Inc. 2020 and 2022 Equity Incentive Plans, for services rendered. All of our non-employee directors elected to take their previously earned and accrued compensation for all of these previous years services in common shares and also agreed to increase the ownership guidelines for owning and holding the Company’s common shares. The stock-based compensation for these professional services will be paid quarterly going forward (see Note 9).

On November 21, 2025, the Company entered into an At the Market Offering Agreement (“2025 Titan ATM Agreement”) with Titan Partners to offer and sell registered shares of common stock of the Company at an aggregate offering price of up to $100 million from time to time, at our option, on terms we deem favorable. In 2026, the Company issued 872,838 registered shares of common stock to Titan Partners for an aggregate sales price of $3,479,179 at an average price per share of $3.99. In 2025, the Company issued 589,243 registered shares of common stock to Titan Partners for an aggregate sales price of $2,221,513 at an average price per share of $3.77. At March 31, 2026, the 2025 Titan ATM Agreement has $96.4 million remaining capacity.

2025 Issuances - For the three-months ended March 31, 2025

On February 3, 2025, the Company issued 66,035 registered shares of its common stock for debt-issuance costs equal to 3% of the principal amount of the 2025 Kips Bay Note with a fair value of $319,149.

Issuance of Unregistered Shares of Common Stock

2025 Issuances - For the three-months ended March 31, 2025

Issuance Date | Issued To |  | Fair Value |  |  | Common Shares Issued |
Various | Alvin Fund LLC (“Alvin Fund”) |  | $ | 142,422 |  |  |  | 35,366 |
March 20, 2025 | American Science and Technology Corporation (“AST”) |  | $ | 2,482,200 |  |  |  | 985,000 |
February 28, 2025 | Former LINICO CEO |  | $ | 1,860,000 |  |  |  | 775,000 |
January 27, 2025 | Kips Bay Select LP |  | $ | 212,766 |  |  |  | 44,024 |
Total common shares issued |  |  |  |  |  |  | 1,839,390 |

18

Table of Contents

Noncontrolling Interest

As of March 31, 2026, the liquidation preference of the Company’s Series 1 Convertible Preferred Shares exceeded Bioleum’s net assets, resulting in substantially all of Bioleum’s losses being attributed to the Company.

On February 23, 2026, holders of a majority of all the issued and outstanding convertible preferred stock of Bioleum Corporation authorized amended and restated articles of incorporation for Bioleum that (a) modified certain provisions of the articles that holders that made the Series 2 Preferred Stock that provided that the Series 2 Preferred Stock would convert into 20% of the as-converted common shares outstanding at all times prior to a Qualifying IPO or Deemed Liquidation Event (each as defined in such articles of incorporation), effectively eliminating the anti-dilution protection, and (b) removed the restriction prohibiting the conversion of the Company's Series 1 Preferred Stock into more than 9.9% of the as-converted common shares outstanding, effectively restoring all of the Company's voting rights. Management evaluated the amendment and determined that it represented a modification as opposed to an extinguishment of the existing preferred stock; accordingly, no gain or loss was recognized and the carrying amounts of the Series 1 and Series 2 Preferred Stock were not adjusted. The Company considered its consolidation conclusion and determined that Bioleum continues to be consolidated on the same basis as previously reported and the modifications did not constitute a reconsideration event.

Warrants

Outstanding warrants at March 31, 2026 and December 31, 2025 are as follows:

|  | Number of Warrants as of March 31, 2026 |  |  | Number of Warrants as of December 31, 2025 |  |  | Exercise Price |  |  | Expiration Date
GHF, Inc. |  |  | 20,000 |  |  |  | 20,000 |  |  | $ | 4.56 |  |  | December 31, 2027
GHF, Inc. |  |  | 50,000 |  |  |  | 50,000 |  |  | $ | 4.56 |  |  | December 31, 2027
GHF, Inc. |  |  | 50,000 |  |  |  | 50,000 |  |  | $ | 4.56 |  |  | December 31, 2027
Alvin Fund LLC |  |  | 100,000 |  |  |  | 100,000 |  |  | $ | 4.56 |  |  | December 31, 2027
Underwriter Purchase Warrants |  |  | 1,073,334 |  |  |  | 1,073,334 |  |  | $ | 2.58 |  |  | August 12, 2030
Underwriter Purchase Warrants |  |  | 1,463,636 |  |  |  | — |  |  | $ | 3.16 |  |  | January 28, 2031
Total outstanding warrants |  |  | 2,756,970 |  |  |  | 1,293,334 |  |  |  |  |  |  |

The following table presents our underwriter purchase warrants at March 31, 2026:

Date of Issuance |  | Warrants |  | Initial Exercise Date | Expiration Date |  | Exercise Price |
August 14, 2025 |  |  | 933,334 |  | February 8, 2026 | August 12, 2030 |  | $ | 2.58 |
September 15, 2025 |  |  | 140,000 |  | February 8, 2026 | August 12, 2030 |  | $ | 2.58 |
January 30, 2026 |  |  | 1,272,727 |  | July 27, 2026 | January 28, 2031 |  | $ | 3.16 |
March 3, 2026 |  |  | 190,909 |  | July 27, 2026 | January 28, 2031 |  | $ | 3.16 |

During the three-months ended March 31, 2026 and 2025, no warrants were exercised or expired.

NOTE 11

FAIR VALUE MEASUREMENTS

The following table presents our assets and liabilities measured at fair value on a recurring basis at March 31, 2026:

|  |  |  |  |  | Fair Value Measurements at |
|  |  |  |  |  | March 31, 2026 |
|  |  |  |  |  | Quoted Prices in Active Markets |  |  | Significant Other Observable Inputs |  |  | Significant Unobservable Inputs |
|  | Total |  |  | (Level 1) |  |  | (Level 2) |  |  | (Level 3) |
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Georges Trust derivative |  | $ | 136,114 |  |  | $ | — |  |  | $ | 136,114 |  |  | $ | — |
Total assets measured at fair value |  | $ | 136,114 |  |  | $ | — |  |  | $ | 136,114 |  |  | $ | — |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Marathon SAFE Note |  | $ | 12,000,000 |  |  | $ | — |  |  | $ | — |  |  | $ | 12,000,000 |
Total liabilities measured at fair value |  | $ | 12,000,000 |  |  | $ | — |  |  | $ | — |  |  | $ | 12,000,000 |

The following table presents our assets and liabilities measured at fair value on a recurring basis at December 31, 2025:

|  |  |  |  |  | Fair Value Measurements at |
|  |  |  |  |  | December 31, 2025 |
|  |  |  |  |  | Quoted Prices in Active Markets |  |  | Significant Other Observable Inputs |  |  | Significant Unobservable Inputs |
|  | Total |  |  | (Level 1) |  |  | (Level 2) |  |  | (Level 3) |
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Georges Trust derivative |  | $ | 1,201,114 |  |  | $ | — |  |  | $ | 1,201,114 |  |  | $ | — |
Alvin Fund derivative |  |  | 759,682 |  |  |  | — |  |  |  | 759,682 |  |  |  | — |
Total assets measured at fair value |  | $ | 1,960,796 |  |  | $ | — |  |  | $ | 1,960,796 |  |  | $ | — |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Marathon SAFE Note |  | $ | 12,000,000 |  |  | $ | — |  |  | $ | — |  |  | $ | 12,000,000 |
Total liabilities measured at fair value |  | $ | 12,000,000 |  |  | $ | — |  |  | $ | — |  |  | $ | 12,000,000 |

19

Table of Contents

VALUATION METHODOLOGIES

Following is a description of the valuation methodologies used for the Company's financial instruments measured at fair value on a recurring basis as well as the general classification of such instruments pursuant to the valuation hierarchy.

Derivatives

The Company has several derivatives associated with its common stock including make-whole commitments and debt conversion options. The following tables presents changes in our derivative assets and liabilities for the three-months ended March 31, 2026 and 2025, measured at fair value:

|  | For the Three-Months Ended March 31, 2026 |
|  | As of December 31, 2025 |  |  | (Additions) Deductions |  |  | Change in Fair Value |  |  | Proceeds Received and Payments Made for Change in Contractual Stock Consideration |  |  | As of March 31, 2026 |
Georges Trust derivative |  | $ | 1,201,114 |  |  | $ | — |  |  | $ | (1,194,000 | ) |  | $ | 129,000 |  |  | $ | 136,114 |
Alvin Fund derivative |  |  | 759,682 |  |  |  | — |  |  |  | 471,985 |  |  |  | (1,231,667 | ) |  |  | — |
Total derivative assets (liabilities) at fair value |  | $ | 1,960,796 |  |  | $ | — |  |  | $ | (722,015 | ) |  | $ | (1,102,667 | ) |  | $ | 136,114 |

|  | For the Three-Months Ended March 31, 2025 |
|  | As of December 31, 2024 |  |  | (Additions) Deductions |  |  | Change in Fair Value |  |  | Payments for Decrease in Contractual Stock Consideration |  |  | As of March 31, 2025 |
2025 Kips Bay convertible debt derivative |  | $ | — |  |  | $ | (1,421,645 | ) |  | $ | 501,645 |  |  | $ | — |  |  | $ | (920,000 | )
LINICO acquisition-related payable derivative |  |  | — |  |  |  | (340,000 | ) |  |  | 31,000 |  |  |  | — |  |  |  | (309,000 | )
AST derivative |  |  | — |  |  |  | 480,540 |  |  |  | (88,540 | ) |  |  | — |  |  |  | 392,000 |
Haywood derivative |  |  | 1,529,850 |  |  |  | — |  |  |  | (1,634,908 | ) |  |  | 120,000 |  |  |  | 14,942 |
Total derivative assets (liabilities) at fair value |  | $ | 1,529,850 |  |  | $ | (1,281,105 | ) |  | $ | (1,190,803 | ) |  | $ | 120,000 |  |  | $ | (822,058 | )

At March 31, 2026 and December 31, 2025, the fair value of the derivative assets (George's Trust and Alvin Fund) were based on a trading price of the Company’s shares of $3.05, and $3.76, respectively. At March 31, 2025, fair value of the derivative assets (Decommissioning Services LLC (“Haywood”) and AST) and derivative liabilities (LINICO acquisition-related payable and Kips Bay) were based on a trading price of the Company’s shares of $2.44.

Georges Trust Derivative Instrument

On August 13, 2025, pursuant to that certain promissory note amendment, dated April 22, 2024, between GHF Inc. and the Company, the Company issued 1,500,000 shares of its common stock to Georges Trust with a fair value of $4,755,000 determined by the closing price per share of our common stock of $3.17. If and to the extent that the sale of the shares results in net proceeds greater than $4,653,886, then Georges Trust is required to pay all of such excess proceeds to the Company. If and to the extent that the sale of the shares results in net proceeds less than $4,653,886, then the Company is required to pay Georges Trust equal to such shortfall. Pursuant to the amendment, a true up provision was recognized as a derivative asset in the amount of $101,114 on the date of the amendment. On March 30, 2026, the Company and the Georges Trust entered into a Second Note Amendment Agreement (the “Second Amendment”), pursuant to which the parties agreed to extend the date by which the Company is required to pay any remaining balance due under the Note from April 15, 2026, to July 15, 2026 and increased the total consideration to $4,782,886. During the three-months ended March 31, 2026, the Company paid Georges Trust $129,000 which resulted in a decrease in contractual stock consideration. During the three-months ended March 31, 2026, the Company recorded a loss of $1,194,000 for the change in the fair value of the derivative. At March 31, 2026, Georges Trust holds 1,500,000 shares of the Company's stock (see Note 15). The derivative asset is classified within Level 2 fair value measurement within the fair value hierarchy.

Alvin Fund Derivative Instruments

On August 12, 2025, pursuant to that certain short-term promissory note, the Company issued 1,400,000 shares of its common stock to Alvin Fund with a fair value of $4,438,000 determined by the closing price per share of our common stock of $3.17. If and to the extent that the sale of the shares results in net proceeds greater than $4,504,318, then Alvin Fund is required to pay all of such excess proceeds to the Company. If and to the extent that the sale of the shares results in net proceeds less than $4,504,318, then the Company is required to pay Alvin Fund equal to such shortfall. Pursuant to the amendment, a true up provision was recognized as a derivative liability in the amount of $66,318 on the date of the amendment. During the three-months ended March 31, 2026, the Company recorded a gain of $471,985 for the change in the fair value of the derivative. In the first quarter of 2026, Alvin Fund sold 1,400,000 shares of the Company's stock for net proceeds of $5,592,009. The Company received cash of $1,231,667 representing cash from the sale of the common shares in excess of amounts owed. The derivative asset was classified within Level 2 fair value measurement within the fair value hierarchy. At March 31, 2026, the Company fulfilled our commitment requirements on the make-whole provision and the derivative and the accounting thereto.

Marathon SAFE Note Instrument

On February 28, 2025, Bioleum, the Company's subsidiary, entered into a series of definitive agreements with Virent, which have been assigned to Bioleum and involve the purchase of Bioleum equity as part of Bioleum’s planned Series A Financing (see Note 9). As of February 28, 2025, the Company recognized the Marathon SAFE Note liability of $12.0 million on the condensed consolidated balance sheets in connection with the agreement with Virent and elected to account the Marathon SAFE Note liability under the fair value option. The Marathon SAFE Note liability was estimated with assistance from third-party valuation specialists and valued using a probability weighted present value of the Marathon SAFE Note with the discount factor based on published venture capital rate of returns of 35% and a discounting period range of 0.25 to 0.84 years. At March 31, 2026, the fair value of the Marathon SAFE Note liability was estimated at $12.0 million and valued using a probability weighted present value of the Marathon SAFE Note with the discount factor based on published venture capital rate of returns of 35% and a discounting period range of 0.25 to 0.75 years. The Marathon SAFE Note liability was classified as a Level 3 fair value measurement within the fair value hierarchy.

20

Table of Contents

For the three-months ended March 31, 2026, the range of variables used to calculate the original fair value of the Marathon SAFE Note and the fair value on the dates of conversion are as follows.

Present Value of Marathon SAFE Note | Discount Rate | Period Range
$12.0 million | 35% | 0.25 years to 0.75 years

For the three-months ended March 31, 2025, the range of variables used to calculate the original fair value of the Marathon SAFE Note and the fair value on the dates of conversion are as follows.

Present Value of Marathon SAFE Note | Discount Rate | Period Range
$12.0 million | 35% | 0.25 years to 0.84 years

Great Basin Guarantee

On March 31, 2026, the Company and Great Basin executed the Great Basin Guaranty (see Note 9). As of March 31, 2026, the Company recorded a guarantee liability of $475,000 and a corresponding guarantee long-term asset, measured at fair value at the time the guaranty was executed, on the condensed consolidated balance sheets. The Great Basin Guaranty liability was estimated with the assistance of third-party valuation specialists and valued using a Probability‑Weighted Expected Return Method (“PWERM”), which considers multiple discrete future outcomes and probability‑weights the expected discounted cash flow approach associated with each scenario using a probability weighted present value with the discount factor based on published venture capital rate of returns of 35%. The scenarios used in the valuation included a base case, late failure case and early failure case with probabilities of 95%, 4% and 1%, respectively, with each case scenario reflecting the surety payments anticipated and anticipated repayments. The Great Basin Guaranty liability was classified as a Level 3 fair value measurement within the fair value hierarchy.

Other Financial Instruments

At March 31, 2026, the carrying amount of cash and cash equivalents, notes receivable, equipment deposits, Flux Photon payable, and reclamation bond approximates fair value because of the short-term maturity of these financial instruments.

NOTE 12 NET INCOME (LOSS) PER COMMON SHARE

Basic earnings per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of shares of common stock outstanding during the period. For the three-months ended March 31, 2026 and 2025, all common stock equivalent shares, which is limited to outstanding warrants (Note 10) are antidilutive.

NOTE 13 SEGMENT REPORTING

We have the following segments and reporting units: Fuels, Metals, Mining, Strategic Investments and Corporate. Summarized financial information relating to our reportable segments is provided below. For the Strategic Investments and Corporate Segments, our chief operating decision maker (“CODM”) is our chief executive officer. For our Fuels Segment, our CODM is the President of Bioleum. For the Metals segment, our CODM is the Metals President. For the Mining segment, our CODM is its President and our chief financial officer.

The Company plans, executes and monitors each reporting segment and has dedicated personnel responsible for each reportable segment. Our Fuels Segment represents our lignocellulosic biomass into biointermediates for refining into renewable fuels. Our Metals Segment represents our recycling of electrification products. Our Mining Segment includes our gold and silver mining assets and related real estate. Our Strategic Investments Segment includes our investments in Green Li-ion and SSOF and our Corporate Segment includes all other assets and general corporate costs. Mining revenue is from leasing mineral claims and other real estate.

The Company’s total revenue for the three-months ended March 31, 2026, consisted of the following:

|  | Metals |  |  | Mining |  |  | Strategic Investments |  |  | Corporate |  |  | Bioleum |  |  | Total |
Mining and Real Estate |  | $ | — |  |  | $ | 33,750 |  |  | $ | — |  |  | $ | 4,500 |  |  | $ | — |  |  | $ | 38,250 |
Recycling |  |  | 40,887 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 40,887 |
Decommissioning Services |  |  | 228,383 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 228,383 |
Off-take |  |  | 5,936 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 5,936 |
Total Revenue |  | $ | 275,206 |  |  | $ | 33,750 |  |  | $ | — |  |  | $ | 4,500 |  |  | $ | — |  |  | $ | 313,456 |

The Company’s total revenue for the three-months ended March 31, 2025, consisted of the following:

|  | Metals |  |  | Mining |  |  | Strategic Investments |  |  | Corporate |  |  | Bioleum |  |  | Total |
Mining and Real Estate |  | $ | — |  |  | $ | 32,250 |  |  | $ | — |  |  | $ | 4,800 |  |  | $ | — |  |  | $ | 37,050 |
Decommissioning Services |  |  | 743,912 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 743,912 |
Off-take |  |  | 4,853 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 4,853 |
Total Revenue |  | $ | 748,765 |  |  | $ | 32,250 |  |  | $ | — |  |  | $ | 4,800 |  |  | $ | — |  |  | $ | 785,815 |

For the three-months ended March 31, 2026, three customers, Atlantic Iron & Metals, Southern Company and Virtus Renewables, accounted for over 10% of our revenues. For the three-months ended March 31, 2025, one customer, RWE, accounted for over 10% of our revenues. At March 31, 2026, three customers, Illuminate, Southern Company and Kiewitt, each individually accounted for over 10% of our accounts receivable balance. At December 31, 2025, one customer, RWE, accounted for over 10% of our revenues and two customers, Illuminate and Alpaugh North LLC, accounted for over 10% of our accounts receivable balance. At March 31, 2026, Comstock Metals billed $537,185 of which $274,954 million was for decommissioning services, recycling fees and off-take revenue and $262,231 of which represents fees for recycling services that have not yet been completed and are recognized as deferred revenue. As of March 31, 2026, total deferred revenue for these services were $250,917.

21

Table of Contents

Three-Months Ended |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
March 31, 2026 |  | Metals |  |  | Mining(1) |  |  | Strategic Investments |  |  | Corporate / Other |  |  | Total of Segments before Bioleum Corp. |  |  | Bioleum |  |  | Consolidated |
Revenue |  | $ | 275,206 |  |  | $ | 33,750 |  |  | $ | — |  |  | $ | 4,500 |  |  | $ | 313,456 |  |  | $ | — |  |  | $ | 313,456 |
Cost of goods sold |  | $ | 599,810 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 599,810 |  |  | $ | — |  |  | $ | 599,810 |
Selling and marketing |  | $ | 34,572 |  |  | $ | — |  |  | $ | — |  |  | $ | 322,344 |  |  | $ | 356,916 |  |  | $ | 3,558 |  |  | $ | 360,474 |
General and administrative |  | $ | 1,343,841 |  |  | $ | 316,965 |  |  | $ | 1,487 |  |  | $ | 2,216,069 |  |  | $ | 3,878,362 |  |  | $ | 2,329,937 |  |  | $ | 6,208,299 |
Research and development |  | $ | 53,964 |  |  | $ | 2,080 |  |  | $ | — |  |  | $ | — |  |  | $ | 56,044 |  |  | $ | 2,040,198 |  |  | $ | 2,096,242 |
Depreciation and amortization |  | $ | 67,059 |  |  | $ | 40,068 |  |  | $ | — |  |  | $ | 19,646 |  |  | $ | 126,773 |  |  | $ | 1,264,611 |  |  | $ | 1,391,384 |
Gain on sale of royalty rights |  | $ | — |  |  | $ | (1,400,010 | ) |  | $ | — |  |  | $ | — |  |  | $ | (1,400,010 | ) |  | $ | — |  |  | $ | (1,400,010 | )
Loss from operations |  | $ | (1,824,040 | ) |  | $ | 1,074,647 |  |  | $ | (1,487 | ) |  | $ | (2,553,559 | ) |  | $ | (3,304,439 | ) |  | $ | (5,638,304 | ) |  | $ | (8,942,743 | )
Total other income (expense), net |  | $ | (629 | ) |  | $ | 49,172 |  |  | $ | — |  |  | $ | (458,270 | ) |  | $ | (409,727 | ) |  | $ | (30,947 | ) |  | $ | (440,674 | )
Net loss |  | $ | (1,824,669 | ) |  | $ | 1,123,819 |  |  | $ | (1,487 | ) |  | $ | (3,011,829 | ) |  | $ | (3,714,166 | ) |  | $ | (5,669,251 | ) |  | $ | (9,383,417 | )
Interest Expense |  | $ | 629 |  |  | $ | 722 |  |  | $ | — |  |  | $ | 85,656 |  |  | $ | 87,007 |  |  | $ | 60,986 |  |  | $ | 147,993 |
Equity method investment loss |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (227,844 | ) |  | $ | (227,844 | ) |  | $ | (24,000 | ) |  | $ | (251,844 | )
Capital Expenditures |  | $ | 5,658,199 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 5,658,199 |  |  | $ | 18,733 |  |  | $ | 5,676,932 |
(1) Mining segment - asset held for sale (see Note 5) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

Three-Months Ended |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
March 31, 2025 |  | Metals |  |  | Mining(1) |  |  | Strategic Investments |  |  | Corporate / Other |  |  | Total of Segments before Bioleum Corp. |  |  | Bioleum |  |  | Consolidated |
Revenue |  | $ | 748,765 |  |  | $ | 32,250 |  |  | $ | — |  |  | $ | 4,800 |  |  | $ | 785,815 |  |  | $ | — |  |  | $ | 785,815 |
Cost of goods sold |  | $ | 886,796 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 886,796 |  |  | $ | — |  |  | $ | 886,796 |
Selling and marketing |  | $ | 13,544 |  |  | $ | — |  |  | $ | — |  |  | $ | 222,842 |  |  | $ | 236,386 |  |  | $ | 988 |  |  | $ | 237,374 |
General and administrative |  | $ | 494,552 |  |  | $ | 164,238 |  |  | $ | 2,786 |  |  | $ | 2,098,114 |  |  | $ | 2,759,690 |  |  | $ | 261,401 |  |  | $ | 3,021,091 |
Research and development |  | $ | 36,627 |  |  | $ | 1,441 |  |  | $ | — |  |  | $ | 1,114,045 |  |  | $ | 1,152,113 |  |  | $ | 2,151,805 |  |  | $ | 3,303,918 |
Depreciation and amortization |  | $ | 62,619 |  |  | $ | 45,288 |  |  | $ | — |  |  | $ | 19,896 |  |  | $ | 127,803 |  |  | $ | 247,581 |  |  | $ | 375,384 |
Loss from operations |  | $ | (745,373 | ) |  | $ | (178,717 | ) |  | $ | (2,786 | ) |  | $ | (3,450,097 | ) |  | $ | (4,376,973 | ) |  | $ | (2,661,775 | ) |  | $ | (7,038,748 | )
Total other income (expense), net |  | $ | — |  |  | $ | (1,589,477 | ) |  | $ | 31,000 |  |  | $ | (419,608 | ) |  | $ | (1,978,085 | ) |  | $ | (77,098 | ) |  | $ | (2,055,183 | )
Net loss |  | $ | (745,373 | ) |  | $ | (1,768,194 | ) |  | $ | 28,214 |  |  | $ | (3,869,705 | ) |  | $ | (6,355,058 | ) |  | $ | (2,738,873 | ) |  | $ | (9,093,931 | )
Interest Expense |  | $ | — |  |  | $ | 921 |  |  | $ | — |  |  | $ | 572,714 |  |  | $ | 573,635 |  |  | $ | 85,509 |  |  | $ | 659,144 |
Equity method investment income |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 41,438 |  |  | $ | 41,438 |  |  | $ | — |  |  | $ | 41,438 |
Acquisitions to intangible assets |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 180,000 |  |  | $ | 180,000 |
Capital Expenditures |  | $ | 206,822 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 206,822 |  |  | $ | 34,051 |  |  | $ | 240,873 |
(1) Mining segment - asset held for sale (see Note 5) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

22

Table of Contents

As of March 31, 2026 |  | Metals |  |  | Mining(1) |  |  | Strategic Investments |  |  | Corporate / Other |  |  | Total of Segments before Bioleum Corp. |  |  | Bioleum |  |  | Consolidated |
ASSETS |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 38,559 |  |  | $ | 69,904 |  |  | $ | — |  |  | $ | 48,967,393 |  |  | $ | 49,075,856 |  |  | $ | 3,891,945 |  |  | $ | 52,967,801 |
Accounts receivable |  | $ | 311,600 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 311,600 |  |  | $ | — |  |  | $ | 311,600 |
Derivative assets |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 136,114 |  |  | $ | 136,114 |  |  | $ | — |  |  | $ | 136,114 |
Other current assets |  | $ | 123,791 |  |  | $ | 15,772 |  |  | $ | — |  |  | $ | 438,373 |  |  | $ | 577,936 |  |  | $ | 241,784 |  |  | $ | 819,720 |
Assets held for sale |  | $ | — |  |  | $ | 22,420,250 |  |  | $ | — |  |  | $ | 312,043 |  |  | $ | 22,732,293 |  |  | $ | — |  |  | $ | 22,732,293 |
Total current assets |  | $ | 473,950 |  |  | $ | 22,505,926 |  |  | $ | — |  |  | $ | 49,853,923 |  |  | $ | 72,833,799 |  |  | $ | 4,133,729 |  |  | $ | 76,967,528 |
Non-current Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments |  | $ | — |  |  | $ | — |  |  | $ | 55,348,221 |  |  | $ | — |  |  | $ | 55,348,221 |  |  | $ | 1,055,371 |  |  | $ | 56,403,592 |
Properties, plant and equipment, net |  | $ | 15,331,016 |  |  | $ | 79,030 |  |  | $ | 6,328,338 |  |  | $ | 24,152 |  |  | $ | 21,762,536 |  |  | $ | 14,333,844 |  |  | $ | 36,096,380 |
Intangible assets, net |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 23,962,994 |  |  | $ | 23,962,994 |
Goodwill |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 1,507,154 |  |  | $ | 1,507,154 |
Other assets |  | $ | 8,452,245 |  |  | $ | 913,754 |  |  | $ | 730,596 |  |  | $ | 475,000 |  |  | $ | 10,571,595 |  |  | $ | 12,624,290 |  |  | $ | 23,195,885 |
Total non-current assets |  | $ | 23,783,261 |  |  | $ | 992,784 |  |  | $ | 62,407,155 |  |  | $ | 499,152 |  |  | $ | 87,682,352 |  |  | $ | 53,483,653 |  |  | $ | 141,166,005 |
TOTAL ASSETS |  | $ | 24,257,211 |  |  | $ | 23,498,710 |  |  | $ | 62,407,155 |  |  | $ | 50,353,075 |  |  | $ | 160,516,151 |  |  | $ | 57,617,382 |  |  | $ | 218,133,533 |
(1) Mining segment - asset held for sale (see Note 5) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

As of December 31, 2025 |  | Metals |  |  | Mining(1) |  |  | Strategic Investments |  |  | Corporate / Other |  |  | Total of Segments before Bioleum Corp. |  |  | Bioleum |  |  | Consolidated |
ASSETS |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 183,458 |  |  | $ | 149,060 |  |  | $ | — |  |  | $ | 9,425,807 |  |  | $ | 9,758,325 |  |  | $ | 7,193,320 |  |  | $ | 16,951,645 |
Accounts receivable |  | $ | 287,874 |  |  | $ | (152 | ) |  | $ | — |  |  | $ | — |  |  | $ | 287,722 |  |  | $ | 1,000,000 |  |  | $ | 1,287,722 |
Derivative assets |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 1,960,796 |  |  | $ | 1,960,796 |  |  | $ | — |  |  | $ | 1,960,796 |
Other current assets |  | $ | 96,180 |  |  | $ | 1,975 |  |  | $ | — |  |  | $ | 166,977 |  |  | $ | 265,132 |  |  | $ | 192,684 |  |  | $ | 457,816 |
Total current assets |  | $ | 567,512 |  |  | $ | 150,883 |  |  | $ | — |  |  | $ | 11,553,580 |  |  | $ | 12,271,975 |  |  | $ | 8,386,004 |  |  | $ | 20,657,979 |
Non-current Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments |  | $ | — |  |  | $ | — |  |  | $ | 38,426,065 |  |  | $ | — |  |  | $ | 38,426,065 |  |  | $ | 1,079,371 |  |  | $ | 39,505,436 |
Properties, plant and equipment, net |  | $ | 2,387,121 |  |  | $ | 7,160,772 |  |  | $ | 6,328,338 |  |  | $ | 355,841 |  |  | $ | 16,232,072 |  |  | $ | 13,654,137 |  |  | $ | 29,886,209 |
Intangible assets, net |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 24,943,388 |  |  | $ | 24,943,388 |
Goodwill |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 1,507,154 |  |  | $ | 1,507,154 |
Other assets |  | $ | 13,563,776 |  |  | $ | 16,109,357 |  |  | $ | 730,596 |  |  | $ | 9,400,000 |  |  | $ | 39,803,729 |  |  | $ | 13,300,742 |  |  | $ | 53,104,471 |
Total non-current assets |  | $ | 15,950,897 |  |  | $ | 23,270,129 |  |  | $ | 45,484,999 |  |  | $ | 9,755,841 |  |  | $ | 94,461,866 |  |  | $ | 54,484,792 |  |  | $ | 148,946,658 |
TOTAL ASSETS |  | $ | 16,518,409 |  |  | $ | 23,421,012 |  |  | $ | 45,484,999 |  |  | $ | 21,309,421 |  |  | $ | 106,733,841 |  |  | $ | 62,870,796 |  |  | $ | 169,604,637 |
(1) Mining segment - asset held for sale (see Note 5) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

23

Table of Contents

NOTE 14 RELATED PARTY TRANSACTIONS

The following related party transactions occurred during the three-months ended March 31, 2026 and 2025.

TRANSACTIONS INVOLVING SIERRA SPRINGS OPPORTUNITY FUND

At December 31, 2025, the Company had an advance to SSOF of $9,400,000. During the three-months ended March 31, 2026, the Company advanced an additional $5,750,000. On March 26, 2026, all advances, totaling $15,150,000 were contributed in exchange for 23,307,692 shares of SSOF common stock at $0.65 per share. On March 30, 2026, the Company subscribed to and invested an additional $2,000,000 for 3,076,923 additional shares of SSOF common stock, also at $0.65 per share. These investments increased the Company's ownership to 40.66% (see Notes 3 and 4). At March 31, 2026 and December 31, 2025, the Company owns 37,620,726 and 11,236,111 shares, respectively, of SSOF common stock, representing an ownership of 40.66% and 16.99%, respectively, on a fully diluted, if converted basis. SSOF is a qualified opportunity zone fund, which owns 100% of Sierra Springs Enterprises Inc. (“SSE”), a qualified opportunity zone business (see also Notes 3 and 4). SSE and its subsidiaries own or control approximately 2,200 acres of land, a manufacturing facility, significant junior and effluent water rights, sewer rights and also owns and operates Sierra Clean Processing LLC and the Silver Springs Regional Airport LLC.

The Company's chief executive officer co-founded SSOF and SSE, and serves as the principal executive officer of SSOF and as an executive of SSE along with a diverse team of qualified financial, capital markets, real estate and operational professionals that together govern, lead and manage SSOF and SSE. Our chief executive officer and two of our directors have separately invested $525,000 into SSOF consisting of 6,624,333 voting shares of SSOF which represents 7.16% of the total as converted SSOF shares of common stock. The Company's chief executive officer has not received compensation from either SSOF or SSE.

TRANSACTIONS INVOLVING FLUX PHOTON

On September 7, 2021, the Company entered into the FPC Asset Purchase Agreement (as defined below) with Flux Photon to acquire the Flux Photon Assets. The purchase price payable for the Flux Photon Assets was $18,000,000 payable in cash to Flux Photon at a rate equal to 20% of the future monthly consolidated sales, less total variable costs, less operating expenses, maintenance, tax payments, and debt service payments of the Company and its now and hereafter-existing subsidiaries, until the purchase price of $18,000,000 has been fully paid. The Company assigned the Flux Photon Assets (as defined below) to the Company immediately after closing. On December 10, 2021, the FPC Asset Purchase Agreement was amended to provide for the payment by the Company of a $350,000 down payment against the purchase price, with a remaining performance-based cash payment of $17,650,000 required under the FPC Asset Purchase Agreement. The Company's former chief technology officer, former director of the Company and former chief executive officer of Bioleum, is also the owner of 100% of the outstanding common stock of Flux Photon and as such was the indirect beneficiary of all payments made to Flux Photon pursuant to the FPC Asset Purchase Agreement.

On December 28, 2023, the Company entered into an amendment (the “2023 FPC Asset Purchase Agreement Amendment”) with Flux Photon to amend that certain Asset Purchase Agreement, dated on September 7, 2021, and amended on December 10, 2021 (as amended, the “FPC Asset Purchase Agreement”). Pursuant to the 2021 FPC Asset Purchase Agreement, the Company acquired certain intellectual property and related photocatalysis laboratory equipment (the “Flux Photon Assets”). The original purchase price included a payable for the Flux Photon Assets of $17,650,000, payable only from 20% of future cash flows defined as the future monthly consolidated sales, less total variable costs, less operating expenses, maintenance, tax payments, and debt service payments of the Company and its now and hereafter-existing subsidiaries until the purchase price has been fully paid. The 2023 FPC Asset Purchase Agreement Amendment reduced the purchase price payable to Flux Photon to $16,850,000. On December 28, 2023, the Company paid $200,000 on this payable which was accounted for as an acquisition of intellectual property. The remaining balance of $16,650,000 will be paid to Flux Photon from future cash flows. During 2024, the Company paid an additional $275,000 to Flux Photon reducing the remaining payable from future cash flows to $16,375,000.

On May 21, 2025, the Company and Flux Photon amended the 2023 FPC Asset Purchase Agreement Amendment (the “2025 FPC Asset Purchase Agreement Amendment”). The original 2021 purchase price included a payable for the Flux Photon Assets of $18,000,000, payable only from 20% of future cash flows defined as the future monthly consolidated sales, less total variable costs, less operating expenses, maintenance, tax payments, and debt service payments of the Company and its subsidiaries until the purchase price was fully paid (the “Earn Out”). From 2021 through May 21, 2025, the Company advanced $1,150,000 in cash and applied an $800,000 discount in consideration for those advance payments, resulting in a remaining balance of $16,050,000 as of May 21, 2025.

Flux Photon Earn Out

On May 21, 2025, in connection with the restructured acquisition of Bioleum and the execution and delivery of the Bioleum Transaction Documents, the Company and Flux Photon entered into the FPC Asset Purchase Agreement Amendment. Under the FPC Asset Purchase Agreement Amendment, the Company committed to a final settlement of $10.0 million of the existing Earn Out obligation. To satisfy this commitment, the Company issued 2,000,000 shares of common stock of the Company, 1,700,000 of such shares went towards settling $10.0 million of the Earn Out, with true up provisions for any proceeds received by Flux Photon that are below or in excess of $10.0 million, and the other 300,000 shares of common stock as settlement with certain Flux Photon affiliates. In 2025, Flux Photon sold all 1,700,000 shares of the Company's stock for net proceeds of $4,726,187 with a remaining amount owed to Flux Photon pursuant to the FPC Asset Purchase Agreement of $5,273,813 which was recognized as Flux Photon payable in the condensed consolidated balance sheet (see Note 15).

Payable to Flux Photon (see Note 7)

Pursuant to the 2025 FPC Asset Purchase Agreement Amendment, the Company is required to pay an additional $6,050,000 cash commitment to Flux Photon for the remaining Earn Out due on the FPC Asset Purchase Agreement. A portion of this remaining obligation to be paid by either the Company, at a rate equal to $120,000 per month for 18 months, and $60,000 per month thereafter, or Bioleum, at a rate of 2% of financing raised by itself, until such time as the entire remaining amount is paid in full settlement of the remaining Earn Out by both the Company and Bioleum. As of March 31, 2026 and December 31, 2025, the Company has paid $1,480,000 and $1,000,000, respectively, directly toward that obligation with the remaining $4,570,000 required to satisfy the Flux Photon cash obligation. Since the payments are not interest bearing, the Company calculated the implied interest of $1,581,383 on the future cash payments using an implied interest rate of 9.76% which was recognized as a discount on the obligation of $6,050,000 to be recognized over the payment term. As of March 31, 2026, the liability has a balance of $3,430,278, net of imputed interest, consisting of a short-term payable of $877,629 (see Note 7) and long-term payable of $2,552,649 in Flux Photon payable in the condensed consolidated balance sheet for future payments due under the 2025 FPC Asset Purchase Agreement Amendment. For the three-months ended March 31, 2026 and 2025, the Company recognized interest expense of $111,946 and $0, respectively, which represents the amortization of the discount that was recognized on the date of the agreement since the payable associated with the commitment is non-interest bearing.

24

Table of Contents

|  | As of March 31, 2026 |  |  | As of December 31, 2025 |
Flux Photon earn out |  | $ | 5,273,813 |  |  | $ | 5,273,813 |
Payable to Flux Photon |  |  | 3,430,278 |  |  |  | 3,793,487 |
Total Flux Photon payable |  | $ | 8,704,091 |  |  | $ | 9,067,300 |
Less: current payable |  |  | (877,629 | ) |  |  | (1,143,412 | )
Long-term Flux Photon payable |  | $ | 7,826,462 |  |  | $ | 7,923,888 |

BIOLEUM FOUNDERS SHARES

On May 22, 2025, Bioleum issued 2.0 million Series 2 Convertible Preferred Shares to the Founders Group in exchange for the assignment of developed technologies. A member of the Founders Group is an immediate family member of the chief executive officer. Additionally, the Founder’s Group included two former officers of the Company and one former officer and director of the Company.

TRANSACTIONS INVOLVING COMSTOCK METALS

In 2023, the Company acquired a metal recycling furnace from the Metals President for a $375,000 payable from a portion of future excess cash flows. As of December 31, 2025 and 2024, the furnace is included in property, plant, and equipment, net, and the related obligation is recorded in other long-term liabilities. For the three-months ended March 31, 2026 and 2025, The Company recognized depreciation expense of $4,688 on the furnace.

On December 22, 2025, Comstock Metals, a wholly owned subsidiary of the Company, entered into a Profit Interest Award Agreement with the Metals President. Pursuant to the agreement, all units vest on achieving a performance condition for the sale and/or liquidation of Comstock Metals if the Metals President remains employed through December 22, 2030.

OTHER

Sierra Clean Processing LLC, a wholly owned subsidiary of SSOF, owns the buildings at 600 Lake Avenue, Silver Springs, Nevada which the Company entered into a Building Lease on August 15, 2023. Sierra Clean Processing LLC also owns the building at 700 Lake Avenue, Silver Springs, Nevada which the Company entered into a Real Estate and Building Lease on August 1, 2024 (see Note 8). Sierra Clean Processing LLC also owns the land at 800 Lake Avenue, Silver Springs, Nevada which the Company entered into a Storage Lease on November 1, 2025 (see Note 8). The Company's chief executive officer is an executive and director of Sierra Clean Processing LLC.

NOTE 15 SUBSEQUENT EVENTS

On April 6, 2026, the Company issued to Flux Photon 1,750,000 shares of common stock of the Company with a fair value of $6,055,000 determined by the closing price per share of our common stock of $3.46, to settle the remaining obligations of the Earn Out of $5,273,813 (see Note 14). If and to the extent that the sale of the shares results in net proceeds greater than $5,273,813, then Flux Photon is required to pay all of such excess proceeds to the Company. If and to the extent that the sale of the shares results in net proceeds less than $5,273,813, then the Company is required to pay Flux Photon equal to such shortfall.

From April 6, 2026 through April 16, 2026, the Company issued a total of 63,944 shares of common stock of the Company to our non-employee directors for annual director services for the period from April 1, 2026 through June 30, 2026, pursuant to the shareholder approved Comstock Inc. 2020 and 2022 Equity Incentive Plans, for services rendered.

On April 30, 2026, the Company invested an additional $2,000,000 into SSOF for an additional 3,076,923 shares of SSOF common stock, also at $0.65 per share. These investments increased the Company's ownership to approximately 42.57%.

On May 6, 2026, the Company was notified that Georges Trust had sold the previously issued 1,500,000 shares of the Company’s common stock in connection with extinguishing a promissory note payable in 2025 (see Note 11). The net proceeds from the sale of those shares exceeded the amounts required to extinguish the principal and interest due on the note by approximately $500,000 which will be received by the Company in the second quarter of 2026.

25

Table of Contents

ITEM 2 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis provides information that management believes is relevant to an assessment and understanding of our condensed consolidated financial condition and results of operations. This discussion should be read in conjunction with the Condensed Consolidated Financial Statements, footnotes and the risk factors included herewith and herein.

OVERVIEW

Comstock commercializes innovative technologies, systems and supply chains that extract, process, and convert under-utilized waste and natural resources into clean energy and clean energy supporting products, including truly sustainable solutions that produce renewed and repurposed electrification metals and minerals from end-of-life solar panels. We approach industrial growth opportunities by identifying, acquiring, and building companies with the potential for superior financial returns on deployed capital, by systematically creating and operating industrial enterprises and systems from the ground up, typically in full equity-based alignment with the founders of the technologies, and then developing, integrating and commercializing their breakthrough technology-based solutions through a distinctive combination of operational and organizational scale-up expertise. Comstock Metals and Bioleum Corporation represent the two leading examples of actualizing our strategy, wherein the founders' groups have a meaningful stake (up to 20% of the subsidiaries' equity or comparable form of profit interest) that is fully restricted until major monetization events occur.

Comstock Metals has established the goal of setting the global standard for solar panel recycling. Our process creates no waste, generates no landfilled materials, and results in clean recycled products that are safe for reuse.

Bioleum seeks to commercialize technologies, systems and supply chains that produce renewable fuels from waste, purpose grown energy crops and other forms of woody biomass.

We approach the challenge of sustainability head-on by innovating, developing and commercializing technologies that accomplish more while utilizing fewer natural resources, protecting our ecosystem from the negative impact of carbon emissions and toxic materials, and enabling and empowering the next industrial revolution. Our plans to generate these throughputs involve both deploying and licensing our technologies within a purpose-driven and designed ecosystem, including extended and interdependent partners that leverage their infrastructures, capacities, and resources, that are often directly integrated with our system.

Our strategic assets for Bioleum include two Wisconsin renewable fuels demonstration facilities, two pilot farms for purpose grown energy crops, a site in Tulsa, Oklahoma for our first fully integrated biorefinery, and for Metals, an existing Nevada-based solar panel recycling demonstration facility and a first-of-its-kind industry-scale solar panel recycling facility that we are currently installing, testing and commissioning.

We also own and manage investments in various legacy assets that previously supported our current or prior businesses that we are working to monetize. This includes our legacy gold and silver mining assets, real estate assets and certain non-strategic investments. This includes northern Nevada real estate that we own, control and/or manage comprised of industrial and commercial land, water rights, other direct investments and about seven square miles of patented and unpatented mining claims and surface parcels, some of which contain significant amounts of measured, indicated, and inferred gold and silver mineral resources.

Lines of Business

Metals Segment

Our Metals Segment utilizes solar panel recycling and materials recovery solutions that drive sustainability across the electrification products market. From 2024 through 2026, we operated a permitted, demonstration-scale solar panel recycling facility that delivers environmentally superior, zero-landfilled recycling solutions to support U.S. mineral industries. For the three-months ended March 31, 2026 and 2025, this facility generated revenues of $0.3 million and $0.7 million, respectively, from service fees for decommissioning services, recycling and processing end-of-life solar panels, and offtake sales of high-value recycled materials, including aluminum, copper, glass, and concentrated precious metals. We believe this technology deployment is globally leading and positioned to operate a world-class, quality, global solar panel recycling operation and has the potential to set the global standard for solar panel recycling and ultimately, a global worldwide recycling network deployment.

Comstock Metals has completed all permitting requirements for its first industry-scale production facility, located on the same campus as the operating demonstration-scale facility. The cost of equipment and installation is estimated to be approximately $14 million. Equipment arrival and installation began in the first quarter of 2026, and commissioning of the plant is expected to be completed in the second quarter with operations coming on-line shortly thereafter. This plant is expected to scale to a production capacity to over 3 million panels per year representing up to 100,000 tons of processed waste materials per year. This strategically located facility will enable the expeditious transition of proven processes from commercial demonstration to full-scale production. The industry-scale facility is expected to enhance our ability to meet the rapid and continuously growing demand for domestically recovered metals. Comstock Metals has selected and submitted state-level permits for a second industry-scale production facility in southern Nevada.

Our plan supports the creation of a more robust domestic supply chain for critical materials by innovating and scaling sustainable recycling technologies. The Company plans to build up to seven facilities in the United States over the next five years and support American energy and resource independence while simultaneously delivering significant economic and environmental value.

Our Metals Segment's 2026 objectives included (1) finalizing commercial plant equipment installation, (2) commissioning of commercial plant, (3) securing larger and longer terms supply contracts (4) select site number two, three and four and begin permitting for site number two, (5) ensure financing for Comstock Metals to sufficiently fund the construction and commissioning of the Company’s second industry-scale facility (6) ordering all of the industry-scale equipment for our second industry-scale facility, (7) finalize the design for downstream recovery of the solar tailings, (8) extend and operate an upgrading line capable of making high specification glass materials and metallurgical grade Silicon metal from scrap OEM materials, and (9) operate one ton per day pilot that can recover silver products and initially create concentrated “other metal” slurries we will use for subsequent Dore’ production. We believe we are on track for completing all of our 2026 objectives.

Mining Segment

Our Mining Segment is administered by our wholly owned subsidiaries, Comstock Mining LLC, Comstock Processing LLC and various other local subsidiaries that collectively own approximately seven square miles of patented mining claims, unpatented mining claims and surface parcels in Nevada, comprising the Comstock Mineral Estate.

26

Table of Contents

On December 18, 2024 and amended on June 6, 2025, the Company executed a membership interest purchase agreement (the “Mackay MIPA”) with Mackay Precious Metals Inc. (“Mackay”) pursuant to which the Company sold all of its right, title, and interest in its wholly owned subsidiary Comstock Northern Exploration LLC, and the Company's 25% interest in Pelen Limited Liability Company (“Pelen”), for an aggregate purchase price of $2,950,000. Pursuant to a royalty agreement between the Company and Mackay, dated December 18, 2024 (the “Mackay Royalty Agreement”) the Company was to receive a 1.5% royalty of Net Smelter Returns (as such term is defined in the Mackay Royalty Agreement). On January 9, 2026, the Company and Mackay entered into a Royalty Purchase and Sale Agreement, wherein the Company sold to Mackay 100% of the Company’s right, title, and interest in and to a 1.5% net smelter returns royalty covering certain patented and unpatented mining claims and leased properties located in Storey County, Nevada, for an aggregate purchase price of $1,100,000, all of which was received on or before January 20, 2026. On February 22, 2026, the Company agreed to a minor modification to the non-compete language associated with the prior purchase of properties by Mackay and received an additional $300,000 in consideration from Mackay. The Company recognized the purchase price of $1,100,000 and the additional $300,000 received in connection with the non-compete modification as gain on sale of royalty rights in the condensed consolidated statements of operations.

In the first quarter of 2026, the Company committed a plan to sell the mining assets and related mining entities. The related assets and liabilities were classified as Held for Sale and $22,732,293 was classified as Assets Held for Sale and $6,651,319 was classified as Liabilities Held for Sale on the condensed consolidated balance sheet as of March 31, 2026.

Our Mining Segment's 2026 objectives are focused on (1) monetizing our mining assets, (2) maximizing the associated cash proceeds and potential retained upside and (3) realizing the ongoing cost savings benefits from a realigned, simpler and more focused enterprise. We believe we are on track for completing all of our 2026 objectives.

Fuels Segment - Bioleum Corporation

Our Fuels Segment is administered by Bioleum and we hold an investment in Bioleum, through our Preferred Series 1 equity position. Bioleum seeks to deliver advanced lignocellulosic biomass refining solutions that set new industry standards for the production of cellulosic ethanol, gasoline, renewable diesel, sustainable aviation fuel, and other renewable Bioleum™ fuels, with extremely low carbon intensity scores of 15 and market-leading yields of up to 125 gallons per dry metric ton of feedstock (on a gasoline gallon equivalent basis), depending on feedstock, site conditions, and other process parameters. In December 2025, Bioleum completed the acquisitions of Hexas Biomass Inc. (“Hexas”) (see Note 2 of the Notes to Consolidated Financial Statements) and substantially all of the patents and other intellectual property assets of RenFuel K2B AB (“RenFuel IP”), including RenFuel IP’s patented catalytic esterification process to refine Bioleum’s proprietary biointermediates. Bioleum is now capable of producing its own purpose grown energy crops used in producing our liquid fuels applications with proven yields exceeding 25 to 30 dry metric tons per acre per year. The combination of Bioleum’s high yielding refining platform and Hexas’ high yielding energy crops enables the production of enough feedstock to produce upwards of 100 barrels (at 42 gallons per barrel) of fuel per acre per year, with regenerative practices that can effectively transform marginal agricultural lands into perpetual “drop-in sedimentary oilfields” with the potential to dramatically boost regional energy security and rural economies. Bioleum plans to contribute to domestic energy dominance by directly building, owning, and operating a network of Bioleum refineries in the U.S., starting with its planned first 400,000 barrel per year commercial demonstration facility in Oklahoma. Bioleum will also license its advanced feedstock and refining solutions to third parties for additional production in global markets. Bioleum does not currently generate revenue.

Bioleum operates two complementary and interdependent pilot facilities, including the Wausau Facility, and the Madison Facility. Bioleum continues innovating its existing commercial process for the purpose of advancing its technological readiness, stabilizing and increasing its market-leading yields, further decreasing carbon intensities, and driving costs down in the longer-term pursuit of fossil parity.

Bioleum’s innovations group has further partnered with other industry leading technologists, including the National Renewable Energy Laboratory, the Massachusetts Institute of Technology, Emerging Fuels Technologies Inc., and others with sponsored research, licensing, and other agreements.

On February 28, 2025, the Company entered into a series of definitive agreements, later assigned to Bioleum, with subsidiaries of Marathon Petroleum Corporation (“Marathon”), involving the purchase of $14,000,000 in Bioleum equity as part of the Series A Financing subject to a $700,000,000 valuation cap. The purchase price includes $1,000,000 in cash and $13,000,000 in payment-in-kind assets comprised of equipment, related intellectual properties, and other materials located at Marathon’s former renewable fuel demonstration facility in Madison, Wisconsin.

In May 2025, Bioleum also completed the initial $20 million closing of its Series A preferred equity offering (“Series A Financing”). Bioleum also plans to complete its Series A Financing during the first half of 2026 and commence project equity and debt financing activities that includes an allocation of up to $160 million from the State of Oklahoma in project activity bonds for the construction of its planned first 400,000 barrel per year facility in Oklahoma.

Strategic Investments Segment

We own and manage several investments and projects that are strategic to our plans and ability to produce and maximize throughput in our Metals and Mining Segments, that are held for the purpose of complementing or enhancing our mission of accelerating the commercialization of hard technologies for the energy transition and creating value but that are not a component of such other segments or otherwise have distinct operating activities. Our Strategic Investments Segment includes minority equity and equity-linked investments in Green Li-ion Pte Limited (“Green Li-ion”) (lithium-ion battery component recycler and remanufacturing) and Sierra Springs Opportunity Fund (northern Nevada real estate).

Investment in Green Li-ion– Our wholly owned LINICO subsidiary owns 35,662 Green Li-ion preferred shares representing 13.34% of Green Li-ion. The Company intends to sell its remaining shares in conjunction with a liquidity event at Green Li-ion.

Investment in SSOF – From 2019 through December 31, 2025, the Company had invested $8,500,000 for 11,236,111 shares in SSOF with an equity ownership of 16.99%. At December 31, 2025, the Company had an advance to SSOF of $9,400,000. During the three-months ended March 31, 2026, the Company advanced an additional $5,750,000. On March 26, 2026, all advances, totaling $15,150,000 were contributed in exchange for 23,307,692 shares of SSOF common stock at $0.65 per share. On March 30, 2026, the Company subscribed to and invested an additional $2,000,000 for 3,076,923 additional shares of SSOF common stock, also at $0.65 per share. These investments increased the Company's ownership to 40.66%. At March 31, 2026, the Company owns 37,620,726 shares in SSOF with an equity ownership of 40.66%. At March 31, 2026, the Company’s maximum exposure to loss as a result of its involvement with SSOF is limited to its investment of $37,147,156.

SSOF is a qualified opportunity zone fund, which owns 100% of Sierra Springs Enterprises Inc. (“SSE”), a qualified opportunity zone business. SSE and its subsidiaries own or control approximately 2,200 acres of land, a manufacturing facility, significant senior, junior and effluent water rights, sewer rights and also owns and operates the Silver Springs Regional Airport LLC. The substantial majority of these properties are contiguous and strategically located within immediate proximity of Highway 50, State Route 439, the Northern Nevada Industrial Center and the Tahoe Reno Industrial Center where high-tech companies like Tesla, Switch, Google, Microsoft, and Tract, and over one hundred other companies are currently located, expanding or locating in this industrializing region.

27

Table of Contents

Other Investment – On March 1, 2024, the Company entered into a Securities Purchase Agreement (the “Developer Securities Purchase Agreement”) with an unaffiliated research and development company (“Developer”) and recognized an initial investment of $1,290,614. Concurrently and in connection with the entry into the Developer Securities Purchase Agreement, the Company and Developer entered into Development Services Agreement (“DSA”) for purposes of conducting certain research and development work. At March 31, 2026, the future remaining payments, net implied interest, totaled $1,284,022. During the three-months ended March 31, 2026 and 2025, the Company paid $0 to the Developer in accordance with the funding commitments under the Developer Securities Purchase Agreement.

Other

Investments in Properties – The Company directly owns three types of properties in Silver Springs, NV, including 98 acres of industrial land, 160 acres of commercial land, both centrally located in Silver Springs, just south of the Silver Springs Regional Airport and a portfolio of water rights. The Company continues to market these assets for sale as both industrial and commercial development as interest in Silver Springs, NV continues to increase.

COMPARATIVE FINANCIAL INFORMATION

Below we set forth a summary of comparative financial information for the three-months ended March 31, 2026 and 2025:

|  | March 31, 2026 |  |  | March 31, 2025 |  |  | Change |
Revenue |  | $ | 313,456 |  |  | $ | 785,815 |  |  | $ | (472,359 | )
Cost of goods sold |  |  | 599,810 |  |  |  | 886,796 |  |  |  | (286,986 | )
Operating Expenses: |  |  |  |  |  |  |  |  |  |  |  |
Selling, general and administrative expenses |  |  | 6,568,773 |  |  |  | 3,258,465 |  |  |  | 3,310,308 |
Research and development |  |  | 2,096,242 |  |  |  | 3,303,918 |  |  |  | (1,207,676 | )
Depreciation and amortization |  |  | 1,391,384 |  |  |  | 375,384 |  |  |  | 1,016,000 |
Gain on sale of royalty rights |  |  | (1,400,010 | ) |  |  | — |  |  |  | (1,400,010 | )
Total operating expenses |  |  | 8,656,389 |  |  |  | 6,937,767 |  |  |  | 1,718,622 |
Loss from operations |  |  | (8,942,743 | ) |  |  | (7,038,748 | ) |  |  | (1,903,995 | )
Other Income (Expense) |  |  |  |  |  |  |  |  |  |  |  |
Interest expense |  |  | (147,993 | ) |  |  | (659,144 | ) |  |  | 511,151 |
Interest income |  |  | 655,304 |  |  |  | 96,109 |  |  |  | 559,195 |
Change in fair value of derivative instruments |  |  | (722,015 | ) |  |  | (1,190,803 | ) |  |  | 468,788 |
Loss on conversion of debt |  |  | — |  |  |  | (1,196,880 | ) |  |  | 1,196,880 |
Gain on extinguishment of liability |  |  | — |  |  |  | 845,000 |  |  |  | (845,000 | )
Other income (expense) |  |  | (225,970 | ) |  |  | 50,535 |  |  |  | (276,505 | )
Total other income (expense), net |  |  | (440,674 | ) |  |  | (2,055,183 | ) |  |  | 1,614,509 |
Net loss |  |  | (9,383,417 | ) |  |  | (9,093,931 | ) |  |  | (289,486 | )
Net loss attributable to noncontrolling interest |  |  | — |  |  |  | — |  |  |  | — |
Net loss attributable to Comstock Inc. |  | $ | (9,383,417 | ) |  | $ | (9,093,931 | ) |  | $ | (289,486 | )

RESULTS OF OPERATIONS

Three-Months Ended March 31, 2026 Compared to Three-Months Ended March 31, 2025

Revenues for the three-months ended March 31, 2026 decreased by $472,359 to $313,456 from $785,815 for the comparable 2025 period, primarily attributed to the following lower revenues from our Metals Segment of $473,559 were attributed to lower decommissioning services resulting from a large emergency decommissioning that occurred in first quarter of 2025.

Revenue and costs of sales in future periods will vary significantly depending on a number of factors, including the amount of solar panels that we recycle and the amount of renewable energy technology solutions that we license and sell, lease revenues on our real properties, the market prices for those services, the extent to which we secure and collect reasonable royalties, the degree to which we can provide event-driven engineering services, and the costs associated with each component of the aforementioned revenues.

Cost of goods sold for the three-months ended March 31, 2026 decreased $286,986 primarily due to the prior year ramp up of our commercial demonstration facility operating for our metal recycling operations.

Selling, general and administrative expense for the three-months ended March 31, 2026 increased by $3,310,308 to $6,568,773 from $3,258,465 in the comparable 2025 period, primarily as a result of higher employee-related costs of $1,539,177 due to higher headcount in 2026 compared to 2025 as we ramp up our metals recycling and biofuels businesses and a payment for incentive compensation of $263,750 in February 2026, compared to a prior year adjustment to lower the 2024 accrued incentive compensation for $600,000, higher rent expense of $525,537 also due to leasing our industry-scale metal recycling facility in Silver Springs, NV and our renewable fuels pilot facilities in Madison, WI. Variance also attributed to higher consulting fees of $388,813, higher legal fees of $225,039, higher director fees of $196,658, higher marketing expense of $128,260 and higher utilities of $119,551.

Research and development expenses for the three-months ended March 31, 2026 decreased by $1,207,676 to $2,096,242 from $3,303,918 in the comparable 2025 period, primarily related to lower rent expense of $1,564,654 attributed to the AST research and development rent of $1,487,476 paid in March 2025 and lower research and development costs for renewable fuel associated projects of $217,920; offset by higher employee-related costs of $566,991 due to higher headcount in 2026 compared to 2025.

28

Table of Contents

Depreciation and amortization for the three-months ended March 31, 2026 increased by $1,016,000 to $1,391,384 from $375,384 in the comparable 2025 period, primarily from higher amortization for intangible asset additions in 2025 and higher depreciation for property, plant and equipment additions in 2025 including the Bioleum Madison facility.

In 2026, we recognized a gain on the sale of royalty rights of $1,400,010 (see Note 5 of the Notes to the Condensed Consolidated Financial Statements).

Interest expense for the three-months ended March 31, 2026 decreased by $511,151 to $147,993 from $659,144 in the comparable 2025 period, primarily due to lower interest and amortization in 2026 compared to in 2025 due to the payoff of obligations.

Interest income for the three-months ended March 31, 2026 increased by $559,195 to $655,304 from $96,109 in the comparable 2025 period, higher interest income related to our cash sweep account and $237,415 of interest income related to the SSOF advances (see Note 4 of the Notes to the Condensed Consolidated Financial Statements).

Change in the fair value of our derivative instruments for the three-months ended March 31, 2026 decreased by $468,788 to a loss of $722,015 from a loss of $1,190,803 in the comparable 2025 period, resulting from a decrease in the Company's share price in connection with potential make whole obligations for minimum value commitments on the Company’s common stock and the change in fair value of conversion option derivatives.

In 2025, loss on the conversion of debt to equity of $1,196,880 was attributed to the 2025 Kips Bay Note.

In 2025, gain on extinguishment of liability of $845,000 was attributed to the restructuring of LINICO acquisition-related payable.

Other income (expense), net for the three-months ended March 31, 2026 were $225,970, primarily consisting of losses from our equity method investments of $251,844.

Other income (expense), net for the three-months ended March 31, 2025 were $50,535, primarily consisting of gain from our equity method investments of $41,438.

OUTLOOK

Comstock Metals has established the goal of setting the global standard for solar panel recycling. Our process creates no waste, no landfilled materials, and results in clean recycled products safe for reuse.

Bioleum seeks to commercialize technologies, systems and supply chains that produce renewable fuels from waste, purpose grown energy crops and other forms of woody biomass, enabling and integrating agricultural and clean energy economics.

The growth opportunities for both Comstock Metals and Bioleum have and continue developing beyond our original plans, and we have now realigned both the organizations and their respective capital bases with some of the most sophisticated partners for investment, feedstocks, technologies, operations, and offtakes, including significant investments.

The Company’s corporate objectives for 2026 include:

• | Monetize our legacy mineral and mining properties, plants and equipment;
• | Secured sufficient power sources for hyper-scale data center developments on our lands in Silver Springs, NV;
• | Restructure, align and expand the ownership in the SSOF and position for high-value monetization;
• | Monetize all other legacy, non-core real estate in Silver Springs, NV; and
• | Support Bioleum development, including the integration and commercialization of Hexas.

The Company’s progress to date has now resulted in two, fully dedicated, high-growth potential companies: our Nevada-based renewable metals operation with expanding, multiple, industry-scale production sites and our Oklahoma-headquartered Bioleum Corporation, with major research, development and pilot production operations based in Wausau and Madison, Wisconsin and Hexas Biomass farming and purpose grown energy crop solutions in Olympia, Washington.

Comstock Metals

Comstock Metals has now been operating its first commercial demonstration facility for nearly two years and in January of 2026, received the final permits for the first industry-scale photovoltaic recycling facility in northern Nevada. Comstock Metals has also selected its second site in the southern part of the State of Nevada. These industry-scale facilities are designed for recycling up to 3.3 million panels (or approximately 100,000 tons) of annual capacity, per production line, with operations for the first facility commencing post first and second quarter 2026 commissioning activities so operations can commence in the second quarter 2026.

Additional site selection activities are ongoing for the next five industry-scale facilities (that is, industry-scale recycling facilities #3-#7) and multiple associated storage sites and at least one centralized, industrial scale refining facility capable of handling the metals-rich tailings produced by its recycling facilities.

The Company's Metals objectives for 2026 include:

• | Receive, deploy, assemble and commission our first industry-scale facility in Silver Springs, NV;
• | Operate our first industry-scale facility in Silver Springs profitably;
• | Secure additional Master Service Agreements with national and regional customers;
• | Advance development efforts, with partners, to recover more and higher-purity materials from recycled streams;
• | Select and secure additional sites, expand storage capabilities and secure permits for these additional sites;
• | Complete site selection for at least three additional solar panel recycling locations and commence permitting;
• | Upgraded downstream production lines for enhanced recoveries, including high specification glass and silver;
• | Submit permits for our second industry-scale facility in southern NV; and
• | Procure our second industry-scale recycling equipment and processing facility and commence commissioning.

29

Table of Contents

The capital expenditures for each of the first and second facilities with 100,000 tons of annual capacity are expected to be approximately $14 million each, which includes expanded storage. Master Service Agreements are being signed with major utility and electronic recycling aggregators across the U.S. and particularly in the southwest regions including California, Arizona and Nevada. Future revenue growth will depend on the rate of customer replacements, pricing, and operating performance as the Company scales production.

Comstock Mining

Comstock Mining has amassed the single largest known land position within the Comstock mineral district, including an extensive repository of drilling data, engineering, and gold and silver resources, including the Lucerne and Dayton resources.

Our Mining Segment's 2026 objectives are focused on (1) monetizing our mining assets, (2) maximizing the associated cash proceeds and (3) realizing the ongoing cost savings benefits from a realigned and more focused enterprise. We believe we are on track for completing all of our 2026 objectives.

Bioleum

Bioleum is actively engaged in the expansion of its pilot production facilities and the planning for its first commercial demonstration facilities and the associated supply chain participants (including feedstock, site selection, engineering, construction and offtake).

Bioleum’s objectives for 2026 include:

• | Complete a “Series B” equity financing for Bioleum;

• | Deploy a Hexas-based, commercial demonstration fuel farm;

• | Expand integrated pilot production capabilities to up to five barrels per week of intermediates and fuels;

• | Commercialize at least one major new project for purpose grown feedstock applications;
• | Commercialize at least one major new project for renewable fuel applications;
• | Commercialize at least one major project that integrates our technology solutions into existing production platforms; and

• | Advance our innovation and development efforts toward even higher yields, lower costs and lower capital.

Bioleum also offers integrations of its solutions into existing agriculture, forestry, pulp and paper, ethanol, and existing petroleum infrastructures to generate additional capacities, revenues, technical services, engineering and royalties. The plans also include integrating Bioleum’s high yield Bioleum refining platform with Hexas’ high yield energy crops to provide enough feedstock to produce upwards of 100 barrels of fuel per acre per year, effectively transforming agricultural lands into perpetual “drop-in sedimentary oilfields” with the potential to dramatically boost domestic energy resources.

Strategic Investments

Investment in Green Li-ion

Green Li-ion continues making meaningful progress in the development and deployment of its system that remanufactures critical PCAM, having now deployed its first commercial battery remanufacturing facility from fully recycled battery materials deployed. The Company intends to sell the remaining 35,662 Green Li-ion preferred shares as soon as Green Li-ion experiences a liquidity event, subject to market conditions.

Investments in other non-mining real estate, water rights and securities

The Company has announced plans for monetizing its mining, non-mining real estate and water rights as soon as practical, also subject to market conditions.

LIQUIDITY AND CAPITAL RESOURCES

Our financial position and liquidity are based on our net sources of capital from financing as generally compared to our net uses of capital from investing activities and ultimately, our ability to provide or use cash flows from or in our operations. Our cash balances at March 31, 2026 and December 31, 2025 were $52,967,801 and $16,951,645, respectively, with $3,891,945 representing Bioleum’s total cash balance at March 31, 2026. The Company had current assets of $76,967,528 and current liabilities of $17,074,453, representing working capital excess of $59,893,075 at March 31, 2026.

The current liabilities include $3,726,467 of accrued expenses, including but not limited to $1,284,022 for certain research and development payables, $877,629 representing the current portion of the Flux Photon earn-out payable, and $1,068,187 for accrued payroll and related expenses.

The Company intends to fund our operations over the next twelve months from existing cash and cash equivalents, planned sales of non-strategic assets and other investments, sales and deferred revenue from our solar panel recycling business, and issuance of subsidiary-level equity (that is, by Bioleum Corporation). Based on these existing and expected funding sources, management believes we will have sufficient funds to sustain our operations and meet our commitments under our investment agreements during the 12 months following the date of issuance of the consolidated financial statements included herein. While we have been successful in the past in obtaining the necessary capital to support our operations, including registered equity financings from our existing shelf registration statement, non-registered equity placements, non-registered equity issued directly from certain subsidiaries, borrowings, and various other means, there is no assurance we will be able to obtain additional equity capital or other financing, if needed.

Our primary source of liquidity during the first three-months of 2026 and 2025 was cash from financing activities. During the three-months ended March 31, 2026, we generated $56,371,850 in cash from our financing activities and we used $5,823,158 and $14,532,536, respectively, in cash in our operating and investing activities. During the three-months ended March 31, 2025, we generated $9,731,350 in cash from our financing activities and we used $4,962,518 and $1,816,330, respectively, in cash in our operating and investing activities.

30

Table of Contents

The Company continues commercializing its metals recycling lines of business. Comstock Metals has received all permits and is currently commissioning its first industry scale facility, with a capacity of up to 100,000 tons of processed material per year, for capital expenditures of approximately $14 million, including the expansion its existing storage capacity, which is also well under way. The first industry scale facility was funded from equity proceeds. Future industry scale facilities and metal recovery capacities will be funded from prior equity proceeds and future debt proceeds, as needed, including direct term loans or industrial bonds and/or other alternative qualified loan financings. Comstock Metals expects to have at least three industry scale facilities operating with up to 100,000 tons of annual capacity coming online over the next three years (2026 through 2028), with up to four additional industry-scale facilities and expansions and strategically located storage areas that are also being planned across the U.S. markets.

The Company has increasing access to a number of alternative capital resources, including $20 million in proceeds to date from the Bioleum Preferred Series A offering, $92.0 million in gross proceeds from two recent CMPO equity raises, various grant sources, including a recent $3.0 million grant from the State of Oklahoma, and various planned asset sales in 2026 and 2027. The Company is also planning additional “Series B” direct equity investment into Bioleum during 2026, from various known strategic and other investors directly into Bioleum.

On January 28, 2026, the Company announced a Confidentially Marketed Public Offering (“CMPO”) with Titan Partners Group LLC (“Titan Partners”). The Company raised $50 million in gross proceeds before underwriting discounts and commissions and other offering expenses. On January 30, 2026, the Company issued 18,181,819 registered shares of its common stock at a price of $2.75 per share for $50,000,002 and received net proceeds of $46,140,002 pursuant to the equity offering on January 28, 2026. On March 3, 2026, Titan Partners exercised their over-allotment option and placed an additional 2,727,272 registered shares of our common stock at a price of $2.75 per share for additional gross proceeds of $7,499,998 (net proceeds of $6,937,498).

Risks to our liquidity could result from future operating expenditures above management’s expectations, including but not limited to variable and fixed costs associated with solar recycling, research and development, capital expenditures and expansions, selling, general and administrative expenses, and investment related expenditures in excess of anticipated sale proceeds from our non-strategic assets and other investments, declines in the market value of properties planned for sale, or declines in the share price of our common stock that would adversely affect our results of operations, financial condition and cash flows. If we were unable to obtain any necessary additional funds, this could have an immediate material adverse effect on liquidity and raise substantial doubt about our ability to continue as a going concern. In such case, we could be required to limit or discontinue certain business plans, activities or operations, reduce or delay certain capital expenditures or investments, or sell certain assets or businesses. There can be no assurance that we would be able to take any such actions on favorable terms, in a timely manner, or at all.

CRITICAL ACCOUNTING ESTIMATES

There have been no significant changes to the critical accounting estimates disclosed in Management's Discussion and Analysis of Financial Condition and Results of Operations in our 2025 Form 10-K.

ITEM 3 QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Market Prices

Changes in the market price of commodities, including precious metals, critical metals and oil and gas may significantly affect our future profitability and cash flow. Metal and fuel prices fluctuate widely due to factors such as: demand, global production levels, supply chain constraints, investor sentiment, central bank reserves, global conflicts and the value of the U.S. dollar and other currencies.

Interest Rate Risk

The interest rates on our existing long-term debt borrowings are fixed, and as a result, interest due on borrowings are not impacted by changes in market-based interest rates.

There have been no material changes in the market risks discussed in Item 7A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

ITEM 4 CONTROLS AND PROCEDURES

A. Disclosure

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this Quarterly Report on Form 10-Q, with the participation of our Principal Executive Officer and Principal Financial Officer, an evaluation of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 ("Exchange Act") was conducted. Our disclosure controls and procedures are designed to ensure information required to be disclosed in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Exchange Act rules, and such information is accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial Officer, to allow timely decisions regarding required disclosures. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives. Based on that evaluation, our chief executive officer concluded that our disclosure controls and procedures, including controls and procedures designed to ensure that information required to be disclosed by us is accumulated and communicated to our management, were effective as of March 31, 2026, in assuring them in a timely manner that material information required to be disclosed in this report has been properly recorded, processed, summarized and reported.

Changes in Internal Control Over Financial Reporting

During the quarter ended March 31, 2026, there was no change in our internal control over financial reporting that materially affected or is reasonably likely to materially affect our internal control over financial reporting.

31

Table of Contents

PART II - OTHER INFORMATION

ITEM 1 LEGAL PROCEEDINGS

The Company’s metals, mining and related activities are subject to various laws and regulations governing environmental protection. These laws and regulations are frequently changing and generally becoming more restrictive. The Company believes its operations comply with applicable laws and regulations, in all material respects. The Company continuously makes expenditures to comply with such laws and regulations but cannot predict the full amount of such future expenditures.

From time to time, we are involved in claims and proceedings that arise in the ordinary course of business. There are no matters pending that we expect to have a material adverse impact on our business, results of operations, financial condition or cash flows.

ITEM 1A RISK FACTORS

No new risk factors have been identified in addition to the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2025.

ITEM 2 UNREGISTERED SALES OF EQUITY SECURITIES AND USES OF PROCEEDS

None.

ITEM 3 DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4 MINE SAFETY DISCLOSURES

Pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 104 of Regulation S-K, we are required to disclose items believed to be violations of the Federal Mine Safety and Health Act of 1977, any health and safety standard, or any regulation, as administered by the Federal Mine Safety and Health Administration. The required information is included in Exhibit 95 to this Report on Form 10-Q.

ITEM 5 OTHER INFORMATION

During the quarter ended March 31, 2026, no director or officer of the Company adopted or terminated any contract, instruction or written plan for the purchase or sale of securities of the Company intended to satisfy the affirmative defense conditions of “Rule 10b5-1 trading arrangement” or any “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Regulation S-K, Item 408.

32

Table of Contents

ITEM 6 EXHIBITS

The exhibits required to be filed as a part of this Report on Form 10-Q are listed in the Exhibit Index attached hereto, which is incorporated herein by reference.

(1) Exhibits filed as part of this Report:

See Exhibits for which the Exhibit number is noted with an asterisk on the Exhibit Index attached hereto.

Exhibit Number |  | Exhibit
4.1 |  | Underwriter's Purchase Warrant, dated January 28, 2026 (previously filed with the Securities and Exchange Commission on January 30, 2026 as Exhibit 4.1 on the Company's Form 8-K (file number 001-35200/film number 26584244 and incorporated herein by reference).
10.1 |  | Cooperation Agreement between the Company and investor, dated March 23, 2026 (previously filed with the Securities and Exchange Commission on March 25, 2026 as Exhibit 10.1 on the Company's Form 8-K (file number 001-35200/film number 26792655 and incorporated herein by reference).
10.2 |  | Second Note Amendment Agreement between the Company and Georges Trust, dated March 30, 2026 (previously filed with the Securities and Exchange Commission on April 1, 2026 as Exhibit 10.1 on the Company's Form 8-K (file number 001-35200/film number 26828550 and incorporated herein by reference).
31.1* |  | Certification of Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities Exchange Act of 1934, as amended.
31.2* |  | Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities Exchange Act of 1934, as amended.
32.1* |  | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2* |  | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
95* |  | Mine Safety Disclosures.
101* |  | Interactive Data File (Quarterly Report on Form 10-Q, for the periods ended March 31, 2026, furnished in iXBRL (Inline eXtensible Business Reporting Language)). Attached as Exhibit 101 to this report are the following documents formatted in XBRL: (i) the Condensed Consolidated Balance Sheets at March 31, 2026 and December 31, 2025, (ii) the Condensed Consolidated Statements of Operations for the three months ended March 31, 2026 and 2025, (iii) the Condensed Consolidated Statements of Changes in Equity for the three months ended March 31, 2026 and 2025, (iv) the Condensed Consolidated Statements of Cash Flows for three-months ended March 31, 2026 and 2025 and (v) the Notes to Condensed Consolidated Financial Statements, tagged as blocks of text. Users of this data are advised pursuant to Rule 406T of Regulation S-T that this interactive data file is deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.
104 |  | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document contained in Exhibit 101

* Filed herewith.

# Management contract or compensatory plan.

33

Table of Contents

The SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on the date indicated.

COMSTOCK INC.
By: /s/ CORRADO DE GASPERIS
CORRADO DE GASPERIS
Chief Executive Officer
(Principal Executive Officer)
Date: May 7, 2026

By: /s/ JUDD B. MERRILL
JUDD B. MERRILL
Chief Financial Officer
(Principal Financial Officer)
Date: May 7, 2026

34